SE430219B - SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF - Google Patents
SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOFInfo
- Publication number
- SE430219B SE430219B SE7900354A SE7900354A SE430219B SE 430219 B SE430219 B SE 430219B SE 7900354 A SE7900354 A SE 7900354A SE 7900354 A SE7900354 A SE 7900354A SE 430219 B SE430219 B SE 430219B
- Authority
- SE
- Sweden
- Prior art keywords
- catalyst
- parts
- mixture
- optically active
- substituted
- Prior art date
Links
- 239000003054 catalyst Substances 0.000 title claims description 55
- 239000002253 acid Substances 0.000 title description 9
- 150000007513 acids Chemical class 0.000 title description 3
- 230000036571 hydration Effects 0.000 title 1
- 238000006703 hydration reaction Methods 0.000 title 1
- -1 rhodium coordination complex Chemical class 0.000 claims description 36
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 35
- 239000003446 ligand Substances 0.000 claims description 32
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 17
- 229910052703 rhodium Inorganic materials 0.000 claims description 14
- 239000010948 rhodium Substances 0.000 claims description 14
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 150000003284 rhodium compounds Chemical class 0.000 claims description 3
- MHERPFVRWOTBSF-UHFFFAOYSA-N methyl(phenyl)phosphane Chemical group CPC1=CC=CC=C1 MHERPFVRWOTBSF-UHFFFAOYSA-N 0.000 claims description 2
- LBBVAIUDEDVEFY-UHFFFAOYSA-N (4-methoxyphenyl)methylphosphane Chemical compound COC1=CC=C(CP)C=C1 LBBVAIUDEDVEFY-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 87
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 60
- 239000000203 mixture Substances 0.000 description 45
- 239000000243 solution Substances 0.000 description 30
- 238000005984 hydrogenation reaction Methods 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 27
- 230000003287 optical effect Effects 0.000 description 25
- 229910052739 hydrogen Inorganic materials 0.000 description 21
- 239000001257 hydrogen Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 229910052751 metal Inorganic materials 0.000 description 16
- 239000002184 metal Substances 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 13
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 13
- 125000001424 substituent group Chemical group 0.000 description 13
- 239000007795 chemical reaction product Substances 0.000 description 8
- ZMKOZQRDFHXOIH-UHFFFAOYSA-N cyclohexyl-[(2-methoxyphenyl)methyl]-methylphosphane Chemical compound COC1=CC=CC=C1CP(C)C1CCCCC1 ZMKOZQRDFHXOIH-UHFFFAOYSA-N 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 7
- 150000002431 hydrogen Chemical class 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- WGHMKSPHCLPBTN-UHFFFAOYSA-N (2-methoxyphenyl)methyl-methyl-phenylphosphane Chemical compound COC1=CC=CC=C1CP(C)C1=CC=CC=C1 WGHMKSPHCLPBTN-UHFFFAOYSA-N 0.000 description 5
- SSYWXIPQHQHKGX-UHFFFAOYSA-N 2-benzamido-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound C1=C(O)C(OC)=CC(C=C(NC(=O)C=2C=CC=CC=2)C(O)=O)=C1 SSYWXIPQHQHKGX-UHFFFAOYSA-N 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 150000004696 coordination complex Chemical class 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000008729 phenylalanine Nutrition 0.000 description 5
- 125000004437 phosphorous atom Chemical group 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000003283 rhodium Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- VFLJJPXIIVSKKP-UHFFFAOYSA-N 1-methoxy-2-[[methyl(phenyl)phosphoryl]methyl]benzene Chemical compound COC1=CC=CC=C1CP(C)(=O)C1=CC=CC=C1 VFLJJPXIIVSKKP-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 3
- 150000001371 alpha-amino acids Chemical class 0.000 description 3
- 235000008206 alpha-amino acids Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- LMZLQYYLELWCCW-UHFFFAOYSA-N dimethoxy(phenyl)phosphane Chemical compound COP(OC)C1=CC=CC=C1 LMZLQYYLELWCCW-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 150000002994 phenylalanines Chemical class 0.000 description 3
- 150000003003 phosphines Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 2
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 2
- HTDQSWDEWGSAMN-UHFFFAOYSA-N 1-bromo-2-methoxybenzene Chemical compound COC1=CC=CC=C1Br HTDQSWDEWGSAMN-UHFFFAOYSA-N 0.000 description 2
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 2
- IEJPPSMHUUQABK-UHFFFAOYSA-N 2,4-diphenyl-4h-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1C1=CC=CC=C1 IEJPPSMHUUQABK-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- BOKLLMHOBIEELP-UHFFFAOYSA-N CCCP(=O)CC1=CC=CC=C1 Chemical compound CCCP(=O)CC1=CC=CC=C1 BOKLLMHOBIEELP-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 150000003935 benzaldehydes Chemical class 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- INANVXNIFVFBAR-UHFFFAOYSA-N benzyl(methyl)phosphinic acid Chemical compound CP(O)(=O)CC1=CC=CC=C1 INANVXNIFVFBAR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- CBEZXDSNQZZXGP-UHFFFAOYSA-N cyclohexyloxy-[(4-methoxyphenyl)methyl]-methylphosphane Chemical compound CP(CC1=CC=C(C=C1)OC)OC1CCCCC1 CBEZXDSNQZZXGP-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- JXGFKVWTMPAMLL-UHFFFAOYSA-N methyl(phenyl)phosphane;hydrochloride Chemical compound Cl.CPC1=CC=CC=C1 JXGFKVWTMPAMLL-UHFFFAOYSA-N 0.000 description 2
- YAAIIVCJIGGXCA-UHFFFAOYSA-N methyl-phenyl-propylarsane Chemical compound C[As](CCC)C1=CC=CC=C1 YAAIIVCJIGGXCA-UHFFFAOYSA-N 0.000 description 2
- 229910052754 neon Inorganic materials 0.000 description 2
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000003579 shift reagent Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 2
- 239000005052 trichlorosilane Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- XKBHPRKDNYAYEI-UHFFFAOYSA-N (2-methoxyphenyl)methylphosphane Chemical compound COC1=CC=CC=C1CP XKBHPRKDNYAYEI-UHFFFAOYSA-N 0.000 description 1
- NQKWPNDZHVCSKW-ZDUSSCGKSA-N (2s)-2-acetamido-3-(1-acetylindol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)C)C(O)=O)=CN(C(C)=O)C2=C1 NQKWPNDZHVCSKW-ZDUSSCGKSA-N 0.000 description 1
- VYXHVRARDIDEHS-UHFFFAOYSA-N 1,5-cyclooctadiene Chemical compound C1CC=CCCC=C1 VYXHVRARDIDEHS-UHFFFAOYSA-N 0.000 description 1
- 239000004912 1,5-cyclooctadiene Substances 0.000 description 1
- SGVUASDJMDTSKZ-UHFFFAOYSA-N 1-[[cyclohexyl(methyl)phosphoryl]methyl]-2-methoxybenzene Chemical compound COC1=CC=CC=C1CP(C)(=O)C1CCCCC1 SGVUASDJMDTSKZ-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- IEMBHEXZQPUYLB-UHFFFAOYSA-N 2-cyclopentylethyl(phenyl)phosphane Chemical compound C=1C=CC=CC=1PCCC1CCCC1 IEMBHEXZQPUYLB-UHFFFAOYSA-N 0.000 description 1
- VCDUANKYHKNFSH-UHFFFAOYSA-N 4-[benzyl(phenyl)phosphanyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1P(C=1C=CC=CC=1)CC1=CC=CC=C1 VCDUANKYHKNFSH-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000047428 Halter Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001295 alanines Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HIEDUWPOQBEHCE-UHFFFAOYSA-N benzyl-(2-methoxyphenyl)phosphane Chemical compound COC1=CC=CC=C1PCC1=CC=CC=C1 HIEDUWPOQBEHCE-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- DLIJPAHLBJIQHE-UHFFFAOYSA-N butylphosphane Chemical compound CCCCP DLIJPAHLBJIQHE-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- SLLGVCUQYRMELA-UHFFFAOYSA-N chlorosilicon Chemical compound Cl[Si] SLLGVCUQYRMELA-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- PUDIEEJVYDKCIW-UHFFFAOYSA-N cyclohexylmethyl(propan-2-yl)phosphane Chemical compound CC(C)PCC1CCCCC1 PUDIEEJVYDKCIW-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IMDXZWRLUZPMDH-UHFFFAOYSA-N dichlorophenylphosphine Chemical compound ClP(Cl)C1=CC=CC=C1 IMDXZWRLUZPMDH-UHFFFAOYSA-N 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HIOLFROGDAUPLS-UHFFFAOYSA-N ethyl-(4-methylphenyl)-phenylphosphane Chemical compound C=1C=C(C)C=CC=1P(CC)C1=CC=CC=C1 HIOLFROGDAUPLS-UHFFFAOYSA-N 0.000 description 1
- ZAZSASKTAHXEJH-UHFFFAOYSA-N ethyl-phenyl-(2,4,5-trimethylphenyl)phosphane Chemical compound C=1C(C)=C(C)C=C(C)C=1P(CC)C1=CC=CC=C1 ZAZSASKTAHXEJH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XIAJQOBRHVKGSP-UHFFFAOYSA-N hexa-1,2-diene Chemical compound CCCC=C=C XIAJQOBRHVKGSP-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000007172 homogeneous catalysis Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- CEBQGWNXQABKAI-UHFFFAOYSA-N methyl-(4-methylphenyl)-phenylphosphane Chemical compound C=1C=C(C)C=CC=1P(C)C1=CC=CC=C1 CEBQGWNXQABKAI-UHFFFAOYSA-N 0.000 description 1
- UMLJLONQGFCDLO-UHFFFAOYSA-N methyl-phenyl-propylphosphane Chemical compound CCCP(C)C1=CC=CC=C1 UMLJLONQGFCDLO-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- VGARCGGLEUCMSB-UHFFFAOYSA-N phenyl(propyl)phosphane Chemical compound CCCPC1=CC=CC=C1 VGARCGGLEUCMSB-UHFFFAOYSA-N 0.000 description 1
- DHOSYPAFKOKZNK-UHFFFAOYSA-N phenyl(pyridin-2-ylmethyl)phosphane Chemical compound C=1C=CC=NC=1CPC1=CC=CC=C1 DHOSYPAFKOKZNK-UHFFFAOYSA-N 0.000 description 1
- XRBCRPZXSCBRTK-UHFFFAOYSA-N phosphonous acid Chemical compound OPO XRBCRPZXSCBRTK-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- YWFDDXXMOPZFFM-UHFFFAOYSA-H rhodium(3+);trisulfate Chemical compound [Rh+3].[Rh+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O YWFDDXXMOPZFFM-UHFFFAOYSA-H 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- WMUVAMXULTVKIW-UHFFFAOYSA-K tribromorhodium;hydrate Chemical compound O.Br[Rh](Br)Br WMUVAMXULTVKIW-UHFFFAOYSA-K 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- CUGZEDSDRBMZMY-UHFFFAOYSA-N trihydrate;hydrochloride Chemical compound O.O.O.Cl CUGZEDSDRBMZMY-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical group COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1895—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing arsenic or antimony
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2291—Olefins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/34—Halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/825—Osmium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/828—Platinum
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Hydrogen, Water And Hydrids (AREA)
Description
is 20 25 50 55 vsoozsa-7 - V2 utmärkta utbyten av den önskade enantiomeren erhålles ur dylika olefinföreningar,' om man som katalysator an- vänder en förening, som består av ett optiskt aktivt metallkoordínationskomplex, som faller under struktur- formeln M1XnL5 eller M2X2L2, där M1 är rodium, rutenium, íridium eller osmium, M2 är palladium eller platina och Xiär väte, klor; fluor, brom eller joe, n är ett helt tal l eller 5, var och en av symbolerna L representerar en fosfin- eller arsinligand, av vilka minst en är op- tiskt aktiv. En sådan reaktion åskàdliggöres i följande reaktionsschema, där fbsubstituenten är fenyl: Q omg-coon iofla-ofi-coon IH optiskt A _ FH aktiv Acyl katalysator i Acyl Sådana förfaranden för asymmetrisk hydrering är fö- remål för det svenska patentet 7106040-4 (publ.nr. 400 552) och behandlas utförligt i dess beskrivning., gßsubstituenten kan exempelvis vara väte, alkyl,Z substituerad alkyl, aryl, substituerad aryl, aralkyl, amino, bensylamino, dibensylamino, nitro, karboxyl och karboxylester etc. Fackmannen på här ifrågavarande område kan väljavßhsubstituenten ur ett stort antal grupper och man behöver vid detta val endast se till att den önskade 'aëaminosyran erhålles som slutprodukt. excellent yields of the desired enantiomer are obtained from such olefin compounds if a compound consisting of an optically active metal coordination complex falling under the structural formula M1XnL5 or M2X2L2 is used as catalyst. where M1 is rhodium, ruthenium, iridium or osmium, M2 is palladium or platinum and X 1 is hydrogen, chlorine; fluorine, bromine or joe, n is an integer 1 or 5, each of the symbols L representing a phosphine or arsine ligand, at least one of which is optically active. Such a reaction is illustrated in the following reaction scheme, where the fsubstituent is phenyl: Q omg-coon io fl a-o fi-coon IH optically A _ FH active Acyl catalyst in Acyl Such processes for asymmetric hydrogenation are the subject of Swedish patent 7106040-4 (publ No. 55 552) and is treated in detail in its description. The gas substituent may be, for example, hydrogen, alkyl, Z-substituted alkyl, aryl, substituted aryl, aralkyl, amino, benzylamino, dibenzylamino, nitro, carboxyl and carboxyl ester, etc. The person skilled in the art In this field, the substituent can be selected from a large number of groups, and in this choice it is only necessary to ensure that the desired amino acid is obtained as the end product.
Som exempel på.mêaminosyror, vilkas enantiomerer med katalysatorn enligt uppfinningen lätt kan framställas, kan nämnas alanin, p-klorfenylalanin, tryptofan, fenylalanin, 5-(5,4-dihydroxifenyl)-alanin, 5-hydroxitryptofan, lysin, histidin, tyrosin, leucin, glutamsyra och valin.Examples of amino acids whose enantiomers with the catalyst according to the invention can be easily prepared are alanine, p-chlorophenylalanine, tryptophan, phenylalanine, 5- (5,4-dihydroxyphenyl) -alanine, 5-hydroxytryptophan, lysine, histidine, tyrosine, leucine, glutamic acid and valine.
Acylgruppen kan vara substituerad eller osubstituerad och som exempel kan nämnas aoetyl, bensoyl, formyl, propi- onyl, butyryl,toluyl, nitrobensoyl och andra acylvarianter, som användes som skyddsgrupper vid peptidsyntes etc.o Det föredrages att sådan katalytisk hydrering avfß- substituerad-kkacylamído-akrylsyror genomföras i närvaro av en bas. få-substituerade filacylamido-akrylsyror och/eller sal- 10 15 20 25 5 ' '7900354-7 ter därav är förelöpare till de substituerade eller osub- stituerade alaninerna. i Föreningarna med nedanstående strukturformel ger ut- märkta resultat vid hydrering med katalysatorn enligt upp- finningen och representerar därför föreningar, som är spe- ciellt lämpliga för ändamålet: 'm - c = f: - coon H §H Z T representerar väte, karboxyl, osubstituerad eller sub: stituerad alkyl, tienyl, ß-indolyl, ß-imidazolyl, furyl, piperenyl eller BP Cq Dr och var och en av symbolerna B, C och D, den ena oberoen- de av den andra representerar väte, alkyl, karboxyl, hyd- roxyl (och metallsalter därav), alkoxi, halogen, acyloxi, aryloxi, aralkyloxi, amino, a kylamino, nitro eller cyan, Z representerar substituerad eller osubstituerad acyl av Ovan angivet slag och p, q och r är hela tal O-5, varvid summan p+q+r är högst 5.The acyl group may be substituted or unsubstituted and examples include acetyl, benzoyl, formyl, propionyl, butyryl, toluyl, nitrobenzoyl and other acyl variants used as protecting groups in peptide synthesis, etc. It is preferred that such catalytic hydrogenation of decubstituted or substituted -acrylic acids are carried out in the presence of a base. few-substituted fi lacylamido-acrylic acids and / or salts thereof are precursors to the substituted or unsubstituted alanines. The compounds of the following structural formula give excellent results in hydrogenation with the catalyst according to the invention and therefore represent compounds which are particularly suitable for the purpose: 'm - c = f: - coon H §HZT represents hydrogen, carboxyl, unsubstituted or substituted: substituted alkyl, thienyl, β-indolyl, β-imidazolyl, furyl, piperenyl or BP Cq Dr and each of the symbols B, C and D, one independently representing hydrogen, alkyl, carboxyl, hydroxyl (and metal salts thereof), alkoxy, halogen, acyloxy, aryloxy, aralkyloxy, amino, alkylamino, nitro or cyano, Z represents substituted or unsubstituted acyl of the type indicated above and p, q and r are integers O-5 , where the sum p + q + r is at most 5.
En speciellt föredragen utföringsform, som också är belysande för hydrering med katalysatorn enligt uppfin» ningen, är framställningen av de substituerade och osub- stituerade fenylalaninerna genom katalytisk asymmetrisk hydrering. Omättade förelöpare för sådana Obaminosyror kan framställas enligt Erlenmeyers azlaktonsyntes, varvid en substituerad eller osubstituerad bensaldehyd omsättes med en acylglycin, exempelvis acetylglycin, och ättiksyra- anhydrid till azlakton, som hydrolyseras till den omättade förelöparen. En sådan reaktion belyses med följande reak- tionsschema, i vilket.man använder bensaldebyd och acetyl- glycin som exempel på reaktionskomponenter: lO 15 20 25 7900354-7 .i ' 4 O O * n _ n _' _ (1) Q-cfio + cnšc-rëfl-cnacoon + o(c-cH5>2--><\:/>c1¶=c_ :o (2j Q-Qfßç-(lho Ocmçicøofi 1%? W* 9 va CH; f " CH3 .I sådana reaktioner kan substituenterna på fenylgrup- pen väljas från ett stort antal grupper och valet begränsas endast av den fenylalanin, som är den.önskade slutproduk- uten. Dessutom kan det förekomma att sådana substituentgrup- per.själva är förelöpare till substituenter, som önskas i slutprodukten och lätt kan omvandlas till sådana önskade substituenter. Om exempelvis den substituerade bensaldehy- den är vanillin och man önskar framställa 5-(5,4-dihydroxi- fenyl)-alanin, kan den omättade förelöparen vara x-acet- amido-4-hydroxi-5-metoxi-kanelsyra, som skulle ge N-acetyl- 5-(4-hydroxi-5-metoxifenyl)-alanin genom hydrering. Denna kan därefter omvandlas till 5-(5,4-dihydroxifenyl)-alanin genom enkel hydrolys.' g ' 'L-enantiomeren av sådana fenylalaniner är speciellt önskvärda. Sålunda är exempelvis 5-(5,4-dihydroxifenyl)-L- alanin (L-DOPA) välkänd för sin användbarhet för behand- ling av symptomen vid Parkinsons sjukdom. Likaledes har L-fenylalanin visat sig användbar som mellanprodukt för 'framställning av alkylestrarna av L-aspartyl-L-fenylala- nin, som nyligen visat sig vara utmärkta syntetiska söt- medel. - - Enligt förevarande uppfinning avses nu optiskt aktiva hydreringskatalysatorer enligt definitionen i de efter- följande kraven, vilka katalysatorer är lösliga rodium- koordinationskomplex med minst en katalytiskt aktiv fosfin- ligand. Med "lösliga" avses att kataljsatorerna är lösliga i reaktionsmassan och den åsyftade katalysen är följaktligen homogen katalys.An especially preferred embodiment, which is also illustrative of hydrogenation with the catalyst according to the invention, is the preparation of the substituted and unsubstituted phenylalanines by catalytic asymmetric hydrogenation. Unsaturated precursors for such Obamino acids can be prepared according to Erlenmeyer's azlactone synthesis, wherein a substituted or unsubstituted benzaldehyde is reacted with an acylglycine, for example acetylglycine, and acetic anhydride to azlactone, which is hydrolyzed to the unsaturated precursor pair. Such a reaction is illustrated by the following reaction scheme, in which benzaldehyde and acetylglycine are used as examples of reactants: I '4 OO * n _ n _' _ (1) Q-c fi o + cnšc-rë fl- cnacoon + o (c-cH5> 2 -> <\: /> c1¶ = c_: o (2j Q-Qfßç- (lho Ocmçicøo fi 1%? W * 9 va CH; f "CH3. In such reactions, the substituents on the phenyl group may be selected from a large number of groups and the choice may be limited only by the phenylalanine which is the desired end product. In addition, such substituent groups may themselves be precursors to substituents which are desired. If, for example, the substituted benzaldehyde is vanillin and it is desired to produce 5- (5,4-dihydroxyphenyl) -alanine, the unsaturated precursor may be x-acetamido-4. -hydroxy-5-methoxy-cinnamic acid, which would give N-acetyl-5- (4-hydroxy-5-methoxyphenyl) -alanine by hydrogenation, which can then be converted to 5- (5,4-dihydroxyphenyl) -alan The g-L-enantiomer of such phenylalanines is particularly desirable. Thus, for example, 5- (5,4-dihydroxyphenyl) -L-alanine (L-DOPA) is well known for its utility in treating the symptoms of Parkinson's disease. Likewise, L-phenylalanine has been found to be useful as an intermediate for the preparation of the alkyl esters of L-aspartyl-L-phenylalanine, which have recently been found to be excellent synthetic sweeteners. According to the present invention, there are now optically active hydrogenation catalysts as defined in the following claims, which catalysts are soluble rhodium coordination complexes with at least one catalytically active phosphine ligand. By "soluble" is meant that the catalysts are soluble in the reaction mass and the intended catalyst is consequently homogeneous catalysis.
'IVO 45 20 25 BO *iv Rhx(AR*5R5R7)5 X 7900354-7 5 Fosfinliganden kan exempelvis ha formeln AR5R5R7, där A är fosfor och var och en av symbolerna R5, R6 och R? den ena oberoende av den andra representerar en väte- atom; en alkyl- eller alkoxigrupp med 1-42 kolatomer; en substituerad alkylgrupp, i vilken substituenterna är valda bland följande, nämligen amino, karbonyl, aryl, nitro och alkoxi, vilken alkoxi innehåller högst 4 kolatomer; en arylgrupp; en aryloxigruppš en fenylgruPPš en med mindre än 5 substituenter substituerad fenylgrupp, varvid substituen- terna är valda bland följande, nämligen alkoxi och alkyl, hyd- roxi, aryloxi, amino och nitro; cykloalkyl med minst 5 kolatomer; substituerad cykloalkgyl; pyrryl; tienyl; furyl; pyridyl; piperidyl; och 5-kolesteryl. - ' Optisk aktivitet hos metallkoordinationskomplexen enligt uppfinningen ligger hos fosfinliganden. Denna optiska aktivitet kan bero antingen på att det på fosforatomen sitter tre olika grupper eller på att en optiskt aktiv grupp är bunden vid fosforatomen. ' I koordinationsmetallkomplexen behöver endast en ligand vara optiskt aktiv för att katalysatorn enligt upp- i finningen skall fungera.IVO 45 20 25 BO * iv Rhx (AR * 5R5R7) 5 X 7900354-7 The phosphine ligand may, for example, have the formula AR5R5R7, where A is phosphorus and each of the symbols R5, R6 and R? one independently of the other represents a hydrogen atom; an alkyl or alkoxy group having 1-42 carbon atoms; a substituted alkyl group in which the substituents are selected from the following, namely amino, carbonyl, aryl, nitro and alkoxy, which alkoxy contains at most 4 carbon atoms; an aryl group; an aryloxy group; a phenyl group; a phenyl group substituted with less than 5 substituents, the substituents being selected from the following, namely alkoxy and alkyl, hydroxy, aryloxy, amino and nitro; cycloalkyl having at least 5 carbon atoms; substituted cycloalkyl; pyrryl; thienyl; furyl; pyridyl; piperidyl; and 5-cholesteryl. The optical activity of the metal coordination complexes of the invention lies in the phosphine ligand. This optical activity can be due either to the fact that there are three different groups on the phosphorus atom or to the fact that an optically active group is attached to the phosphorus atom. In the coordination metal complex, only one ligand needs to be optically active for the catalyst according to the invention to function.
Om ligandens optiska aktivitet består i att en optiskt aktiv grupp är bunden vid fosforatomen, behöver det endast finnas en sådan grupp och de två andra grupperna kan vara lika eller inaktiva. I detta fall behöver endast en av grupperna R5, R6 eller R? vara optiskt aktiv och de àter- stående tvà grupperna kan vara identiska eller inaktiva.If the optical activity of the ligand is that an optically active group is attached to the phosphorus atom, there need be only one such group and the other two groups may be the same or inactive. In this case, only one of the groups R5, R6 or R? be optically active and the remaining two groups may be identical or inactive.
Användbara katalysatorer faller under följande formler för koordinationsmetallkomplex men de är icke°begränsade till dessa. I formlerna anger en asterisk asymmetri och där- med optisk aktivitet. Asterisken betecknar den asymmetriska atomen eller den disymmetriska gruppen.Useful catalysts fall under the following formulas for coordination metal complexes but are not limited thereto. The formulas indicate an asterisk asymmetry and thus optical activity. The asterisk denotes the asymmetric atom or the disymmetric group.
I Rhx(A*R5R6R7)5 vi: II i Rnx(A*R5R6R7)2(AR5R6R7) VIII III RhX(A*R5R6R7) (AR5R6R7)2 IX RhX5(A*n5R6R7)5 Rnx5(A*R5R6R7)2(AR5R5R7) Rhx5(A*R5R6R7)(AR5R6R7)2 RhX¿(AR*5R5R7)5 Rhx5(AR*5R5R7)2(AR5R5R7) Rnx3(AR*5R5R7)(AR5R“R7)2 v RhX(AR*5R5R7)2(AR5R6R7) xx VI Rhx(AR*5R5R7)(AR5R6R7)2 7900354-7 45 §O I den ovan som.exempel angivna listan av katalysaf torer kan den disymmetriska gruppen vara R5, R6 eller R? och är icke begränsad till någon enstaka grupp. Dessutom kan det förekomma en kombination av grupper bundna vid metallen.I Rhx (A * R5R6R7) 5 vi: II i Rnx (A * R5R6R7) 2 (AR5R6R7) VIII III RhX (A * R5R6R7) (AR5R6R7) 2 IX RhX5 (A * n5R6R7) 5 Rnx5 (A * R5R6R7) 2 ( AR5R5R7) Rhx5 (A * R5R6R7) (AR5R6R7) 2 RhX¿ (AR * 5R5R7) 5 Rhx5 (AR * 5R5R7) 2 (AR5R5R7) Rnx3 (AR * 5R5R7) (AR5R “R7) 2 v RhX (AR * 5R5R7) (AR5R6R7) xx VI Rhx (AR * 5R5R7) (AR5R6R7) 2 7900354-7 45 In the list of catalysts given above as examples, the disymmetric group may be R5, R6 or R? and is not limited to any single group. In addition, there may be a combination of groups attached to the metal.
I Givetvis representerar de ovan angivna formlerna icke endast de koordinationsmetallkomplex, som innehåller två eller tre ligander utan också de koordinationsmetall- komplex, i vilka antalet ligandfmetallkoordinationsbind- ningar är mindre och i vilka bindningar tillhandahållas å'av flertandade ligander. Sålunda kan det exempelvis före- komma att det i komplexet ingår endast två ligander om en av de båda liganderna är tvåtandad, dvs. ger två koordi- _ nationsbindníngar. Idkaledes kan det ingå endast en ligand, om denna är tretandad, dvs. ger tre koordinatíonsbindningar.Of course, the above formulas represent not only the coordination metal complexes containing two or three ligands but also the coordination metal complexes in which the number of ligand-metal coordination bonds is smaller and in which bonds are provided by multi-toothed ligands. Thus, for example, it may happen that the complex includes only two ligands if one of the two ligands is bidentate, ie. gives two coordination bonds. Thus, it can only contain one ligand, if this is three-toothed, ie. makes three coordination bonds.
Bland substituenterna på fosforatomerna kan nämnas metyl, etyl, propyl, isopropyl, butyl, pentyl, hexyl, heptyl, oktyl, nonyl, dekyl, undekyl, dodekyl, cyklopropyl, oyklobutyl, cyklopentyl, cyklohexyl, fenyl, acetoxifenyl, metylfenyl, etylfenyl, propylfenyl, butylfenyl, dimetyl- fenyl, trimetylfenyl, dietylfenyl, hydroxifenyl, fenoxi- fenyl, o-anisyl, 5-kolesteryl, bensyl, pyrryl, furyl, pyrídyl, tienyl, piperidyl, mentyl, bornyl och pinyl.Among the substituents on the phosphorus atoms may be mentioned methyl, ethyl, propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, acetoxyphenyl, methylphenyl, ethylphenyl, ethylphenyl, butylphenyl, dimethylphenyl, trimethylphenyl, diethylphenyl, hydroxyphenyl, phenoxyphenyl, o-anisyl, 5-cholesteryl, benzyl, pyrryl, furyl, pyridyl, thienyl, piperidyl, mentyl, bornyl and pinyl.
Bland de ovannämnda substituenterna fr.o.m. butyl t.o.m. dodecyl innefattas givetvis isomerer därav. Substituen- terna är emellertid icke begränsade till de ovan uppräk- nade.Among the above-mentioned substituents fr.o.m. butyl t.o.m. dodecyl, of course, includes isomers thereof. However, the substituents are not limited to those listed above.
För ändamålet enligt uppfinningen kan följande optiskt aktiva fosfiner användas, men uppfinningen är givetvis icke begränsad till dessa; metyletylfosfin, metylisopropylfosfin, etylbutylfosfin, isopropylisobutylfosfin, metylfenylfosfin, etylfenylfosfin¿ propylfenylfosfin, butylfenylfosfin, fenylbensylfosfin, fenylpyrrolfosfin, etylisopropyliso~ butylfosfin, metylfenyl-4-metylfenylfosfin, etylfenyl-4- metylfenylfosfin, metylisopropylfenylfosfin, lO 15 20 25 50 55 7 7900354 '7 etylfenyl-2,4,5-trimetylfenylfosfin, fenylbensyl-4-di- metylaminofenylfosfin, fenylpyridylmetylfosfin, fenyl- cyklopentyletylfosfin, cyklohexylmetylisopropylfosfin, o-metoxifenylmetylfenylfosfin och o-metoxifenylcyklo- hexylmetylfosfin. D .For the purpose of the invention the following optically active phosphines may be used, but the invention is of course not limited thereto; metyletylfosfin, metylisopropylfosfin, etylbutylfosfin, isopropylisobutylfosfin, methylphenylphosphine, etylfenylfosfin¿ propylfenylfosfin, butylfenylfosfin, fenylbensylfosfin, fenylpyrrolfosfin, etylisopropyliso ~ butylphosphine, methylphenyl 4-methylphenylphosphine, ethylphenyl-4- methylphenylphosphine, metylisopropylfenylfosfin, IO 15 20 25 50 55 7 7900354 '7 ethylphenyl- 2,4,5-trimethylphenylphosphine, phenylbenzyl-4-dimethylaminophenylphosphine, phenylpyridylmethylphosphine, phenylcyclopentylethylphosphine, cyclohexylmethylisopropylphosphine, o-methoxyphenylmethylphenylphosphine and o-methoxyphenylcycloxyphyl. D.
För ändamålet enligt uppfinningen föredrages i syn- nerhet de optiskt aktiva fosfiner som innehåller minst en fenylgrupp, vilken uppbär en substituent i orto-ställ- ningen, exempelvis hydroxi;_alkoxi med 1-12 kolatomer; och aryloxi. Utmärkta resultat har erhållits med metyl- fenyl-o-anisylfosfin och metylcyklohexyl-o-anisylfosfin.For the purpose of the invention, particularly preferred are the optically active phosphines which contain at least one phenyl group which bears a substituent in the ortho position, for example hydroxy; alkoxy having 1 to 12 carbon atoms; and aryloxy. Excellent results have been obtained with methylphenyl-o-anisylphosphine and methylcyclohexyl-o-anisylphosphine.
Den sistnämnda föreningen och de därmed framställda op- tiskt aktiva koordinationsmetallkomplex-hydreringskata- lysatorerna är nya och det har visat sig, att de önskade enantiomererna av substituerade och osubstituerade fenyl- alaniner lätt framställes i utmärkta utbyten, när man an- vänder sådana optiskt aktiva ligander i sättet enligt upp- finningen.The latter compound and the optically active coordinating metal complex hydrogenation catalysts thus prepared are new and it has been found that the desired enantiomers of substituted and unsubstituted phenylalanines are readily prepared in excellent yields when using such optically active ligands. in the manner according to the invention.
Ehuru endast en optiskt aktiv grupp eller ligand erfordras i koordinationsmetallkomplexkatalysatorn före- drages för underlättande av framställningen att alla tre liganderna är inbördes lika. Det föredrages också att asym- metrin ligger hos fosforatomen.Although only one optically active group or ligand is required in the coordination metal complex catalyst, it is preferred to facilitate the preparation that all three ligands be mutually equal. It is also preferred that the asymmetry reside with the phosphorus atom.
Det har visat sig, att utmärkta utbyten av de önska- de enantiomererna kan erhållas, icke endast med de ovan beskrivna optiskt aktiva hydreringskatalysatorerna, som är koordinationsmetallkomplex av rodium utan man kan även erhålla goda utbyten, när hydreringen genomföres i närvaro av en katalysator, som består av en lösning av rodium och minst en ekvivalent av en fosfinligand per mol.rodium' förutsatt att liganden är optiskt aktiv. Som exempel kan nämnas, att katalysatorn kan framställas genom upplösning av en löslig rodiumförening i ett lämpligt lösningsmedel tillsammans med en ligand, varvid förhållandet ligand: metall är minst en ekvivalent ligand per mol rodíum, före- trädesvis tvâ ekvivalenter ligand per mol rodium. Likale- des har det visat sig, att katalysatorn kan framställas in situ genom tillsats av en löslig metallförening till reaktionsmassan tillsammans med en tillsats av den lämp- '7900351P7 ' 8 10 l5 20 25 BO 55 f liga mängden av den optiskt aktiva liganden till reak- tionsmassan antingen före eller under hydreringen.It has been found that excellent yields of the desired enantiomers can be obtained not only with the optically active hydrogenation catalysts described above, which are coordination metal complexes of rhodium, but good yields can also be obtained when the hydrogenation is carried out in the presence of a catalyst which consists of a solution of rhodium and at least one equivalent of one phosphine ligand per mole of rhodium, provided that the ligand is optically active. By way of example, the catalyst may be prepared by dissolving a soluble rhodium compound in a suitable solvent together with a ligand, the ligand: metal ratio being at least one equivalent of ligand per mole of rhodium, preferably two equivalents of ligand per mole of rhodium. Likewise, it has been found that the catalyst can be prepared in situ by adding a soluble metal compound to the reaction mass together with an addition of the appropriate amount of the optically active ligand to react. the mass either before or during the hydrogenation.
Bland användbara, lösliga rodiumföreningar kan nämnas rodiumtriklorhydrat, rodíumtribromidhydrat, rodium- sulfat, organiska rodiumkomplex-med eten, propen etc. och bisolefiner, såsom 1,5-cyklooktadien och 1,5-hexadien, bicyklo-2,2.l-hepta-2,5-dien och andra diener, som kan bilda tvåtandade ligander, eller en aktiv form av metal- liskt rodium, som är lättsolubiliserad; ' I Det har visat sig, att katalysatorn enligt uppfin- ningen företrädesvis innehåller den optiskt aktiva fosfin- liganden i ett förhållande av ca 1,5 till ca 2,5 (före- trädesvis 2,0) ekvivalenter ligand per mol metall. För ' _handhavande och lagring föredrages i praktiken att dens optiskt aktiva katalysatorn är i fast form och det har vi- -sat sig att detta kan uppnås med fasta, katjoniska koor- dinationsmetallkomplex. . .Useful soluble rhodium compounds include rhodium trichlorohydrate, rhodium tribromide hydrate, rhodium sulfate, organic rhodium complexes with ethylene, propylene, etc. and bisolefins such as 1,5-cyclooctadiene and 1,5-hexadiene, bicyclo-2,2,1-hepta- 2,5-diene and other dienes, which can form bidentate ligands, or an active form of metallic rhodium, which is easily solubilized; It has been found that the catalyst of the invention preferably contains the optically active phosphine ligand in a ratio of about 1.5 to about 2.5 (preferably 2.0) equivalents of ligand per mole of metal. For handling and storage, it is preferred in practice that its optically active catalyst be in solid form and it has been found that this can be achieved with solid, cationic coordination metal complexes. . .
Katjoniska koordinationsmetallkomplex innehållande _två ekvivalenter fosfin per mol metall och en kelatbil- dande bis-olefin kan användas som katalysatorer enligt upp- finningen. Sålunda kan man vid användning av de ovan be- skrivna organiska rodiumkomplexen framställa sådana kat- joniska koordinationsrodiumkomplex genom uppslamning av den organiska rodiumkomplexen igen alkohol, exempelvis etanol; tillsätta två ekvivalenter av den optiskt aktiva fosfinen, sä att det bildas en jonlösning, varpå en lämp- lig anjon tillsättes, exempelvis tetrafluorborat, tetra- fenylborat eller vilken som helst annan anjon, som fäller eller utkristalliserar en fast, katjonisk koordinations- metallkomplex antingen direkt ur lösningen eller vid be- handling i ett lämpligt lösningsmedel. lSom exempel på katjoníska koordinationsmetallkomplex kan nämnas cyklooktadíen-l,5-bis(metylcyklohexyl-o-anisyl- fosfin)-rodiumtetrafluorborat, cyklooktadien-l,5-bis(metyl- cyklohexyl-o-anisylfosfin)-rodiumtetrafenylborat och bi- cyklo-2.2.l-hepta-2;5-dien-bis(metylcyklohexyl-o~anisyl- fosfin)-rodiumtetrafluorborat.Cationic coordination metal complexes containing two equivalents of phosphine per mole of metal and a chelating bis-olefin can be used as catalysts according to the invention. Thus, using the organic rhodium complexes described above, such cationic coordination rhodium complexes can be prepared by slurrying the organic rhodium complexes again into alcohol, for example ethanol; add two equivalents of the optically active phosphine to form an ionic solution, then add a suitable anion, for example tetrafluoroborate, tetraphenylborate or any other anion which precipitates or crystallizes a solid cationic coordination metal complex either directly from the solution or during treatment in a suitable solvent. Examples of cationic coordination metal complexes are cyclooctadiene-1,5-bis (methylcyclohexyl-o-anisylphosphine) -rodium tetrafluoroborate, cyclooctadien-1,5-bis (methyl-cyclohexyl-o-anisylphosphine) -rodium tetraphenyl 1-Hepta-2,5-diene-bis (methylcyclohexyl-o-anisyl-phosphine) -rodium tetrafluoroborate.
Utan att binda uppfinningen vid någon speciell teori antages att katalysatorn föreligger i form av ett första- 'IO 15 20 25 30 55 40 9 7900354 -7 dium, som vid kontakt med väte omvandlas till aktiv form.Without limiting the invention to any particular theory, it is believed that the catalyst is in the form of a first-dium which, upon contact with hydrogen, is converted to active form.
Denna omvandling kan givetvis genomföras under själva hydre- ringen av olefinbindningen eller också kan katalysatorn eller förstadiet därav hydreras före tillsatsen till olefinmaterial- et, som skall hydreras.This conversion can of course be carried out during the actual hydrogenation of the olefin bond or the catalyst or its precursor can be hydrogenated before the addition to the olefin material to be hydrogenated.
Hydreringen genomföras vanligtvis i ett sådant lösnings- medel som bensen, etanol, toluen, cyklohexan eller en bland- ning av två eller flera av dessa. Nästan vilken som helst aromat, mättad alkan eller cykloalkan, som är inaktiv gent- emot hydreringsbetingelserna vid hydreringen med katalysatorn enligt uppfinningen kan användas som lösningsmedel. Enär hyd- reringen har visat sig vara specifik kan även sådana lösnings- medel som nitrobensen användas. Som lösningsmedel föredrages emellertid metanol.The hydrogenation is usually carried out in a solvent such as benzene, ethanol, toluene, cyclohexane or a mixture of two or more of these. Almost any aromatic, saturated alkane or cycloalkane which is inactive against the hydrogenation conditions of the hydrogenation with the catalyst according to the invention can be used as solvent. Since the hydrogenation has been shown to be specific, solvents such as nitrobenzene can also be used. However, methanol is preferred as the solvent.
Såsom ovan angivits sättas katalysatorn till lösnings- medlet antingen i form av en förening som sådan eller i form av föreningens komponenter, som i så fall bildar katalysatorn in situ. När katalysatorn tillsättes i form av sina komponen- ter kan dessa tillsättas före eller samtidigt med den ß- substituerade a-acylamidoakrylsyran. Komponenter för fram- ' ställning av katalysatorn in situ är den lösliga metallför- eningen och den optiskt aktiva fosfinliganden.As stated above, the catalyst is added to the solvent either in the form of a compound as such or in the form of the components of the compound, which in that case form the catalyst in situ. When the catalyst is added in the form of its components, these may be added before or simultaneously with the β-substituted α-acylamidoacrylic acid. Components for the preparation of the catalyst in situ are the soluble metal compound and the optically active phosphine ligand.
Katalysatorn kan tillsättes i vilken som helst effektiv katalytisk mängd, vanligtvis i en mängd mellan ca 0,0001 och cirka 5 viktprocent av i katalysatorn ingående metall räknat på mängden B-substituerad a-acylamidoakrylsyra och/eller salt därav. Åtgärder bör inom praktiska gränser vidtagas för und- vikande av kontakt mellænkatalysatorneller reaktionsmassan och oxíderande material. I synnerhet bör man vidtaga försik- tighetsåtgärder för undvikande av kontakt med syre. Det före- drages att preparera hydreringsreaktionen och genomföra själva hydreringen i gaser (andra än H2) som är inerta gentemot båda reaktionskomponenterna och katalysatorerna, exempelvis kväve eller koldioxid. ' Såsom ovan påpekats har det nu visat sig, att den asym- metriska hydreringen ökas genom närvaron av en bas i reak- tionsmassan. Ehuru den asymmetriska hydreringen kan genom- föras i en reaktionsmassa, som är fri från bas och t.o.m. i en sur reaktionsmassa, förbättras utbytet, om man till reak- vanessa-v i v w tionsmassan sätter små mängder av ett basiskt material, nämligen npp till högst en ekvivalent per mol akrylsyra.The catalyst can be added in any effective catalytic amount, usually in an amount between about 0.0001 and about 5% by weight of metal contained in the catalyst based on the amount of B-substituted α-acylamidoacrylic acid and / or salt thereof. Measures should be taken within practical limits to avoid contact between the catalyst or the reaction mass and oxidizing material. In particular, precautions should be taken to avoid contact with oxygen. It is preferred to prepare the hydrogenation reaction and carry out the hydrogenation itself in gases (other than H2) which are inert to both reactants and the catalysts, for example nitrogen or carbon dioxide. As pointed out above, it has now been found that the asymmetric hydrogenation is increased by the presence of a base in the reaction mass. Although the asymmetric hydrogenation can be carried out in a reaction mass which is free from base and up to in an acidic reaction mass, the yield is improved if small amounts of a basic material are added to the reaction mass in the reaction mass, namely npp to at most one equivalent per mole of acrylic acid.
Det är förvånande, att en ringa mängd bas, som sättes till en t.o.m. sur reaktionsmassa ger förbättrad asymmetrisk 5 hydrering och det har visat sig, att bildningen av en ringa mängd salt av akrylsyra är tillräcklig för erhållande av förbättrade resultat. _ 7 Bland användbara baser kan nämnas tertiära baser, såsom trietylamin, vidare NaOH och nästan vilket som helst annat 10 -basiskt material, som bildar ett salt med karboxylsyror.It is surprising that a small amount of base, which is added to a t.o.m. acidic reaction mass gives improved asymmetric hydrogenation and it has been found that the formation of a small amount of salt of acrylic acid is sufficient to obtain improved results. Useful bases include tertiary bases, such as triethylamine, further NaOH and almost any other 10 -basic material which forms a salt with carboxylic acids.
-Efter tillsats av komponenterna till lösningsmedlet tillföres väte till blandningen, till dess att man tillfört imellan cirka 1 och cirka 5 gånger molmängden B-substituerad a-acylamido-akrylsyra eller en mängd, som erfordras för 15 fullständig hydrering till den önskade nivån. Trycket i I systemet varierar med nödvändighet, enär det beror på typen ß-substituerad a-acylamido-akrylsyra, katalysatortypen, 5 hydreringsapparatens dimensioner, mängden komponenter och mängden lösningsmedel och/eller bas. Iägre tryck, inklusive 20 atmosfärstrycket och underatmosfäriskt tryck kan tillämpas liksom även högre tryck. 5 Reakticnstemperaturen kan ligga mellan cirka -20 och cirka 140°C. Högre temperaturer kan tillämpas men erfordras normalt icke och kan leda till att bireaktioner accelereras. 25 När reaktionen slutförts, vilket fastställes på kon- ventionellt sätt, avlägsnas lösningsmedlet och produkterna och katalysatorn avskiljes med vanliga medel.After adding the components to the solvent, hydrogen is added to the mixture, until between about 1 and about 5 times the molar amount of B-substituted α-acylamido-acrylic acid or an amount required for complete hydrogenation to the desired level is added. The pressure in the system necessarily varies, as it depends on the type of β-substituted α-acylamidoacrylic acid, the type of catalyst, the dimensions of the hydrator, the amount of components and the amount of solvent and / or base. Lower pressures, including atmospheric pressure and subatmospheric pressure can be applied as well as higher pressures. The reaction temperature can be between about -20 and about 140 ° C. Higher temperatures can be applied but are not normally required and can lead to accelerated side reactions. When the reaction is complete, which is determined in a conventional manner, the solvent is removed and the products and the catalyst are separated by ordinary means.
Många i naturen förekommande produkter och mediciner _ förekommer i en optiskt aktiv form. I detta fall är vanligt- 50 vis endast I- eller D-formen effektiv. Syntetisk framställ- ning av dessa föreningar har hittills erfordrat ytterligare steg, nämligen separation av produkterna i deras enantiomerer.Many naturally occurring products and medicines _ occur in an optically active form. In this case, usually only the I or D form is effective. Synthetic preparation of these compounds has hitherto required further steps, namely separation of the products into their enantiomers.
Detta är tidskrävande och dyrbart. Katalysatorn enligt upp- finningen möjliggör framställning av optiskt aktiva produkter, 55 7 varigenom nämnda tidskrävande och dyrbara separation elimin- eras samtidigt som utbytena av de önskade enantiomererna ökas cch mängden icke önskad enantiomer minskas. Önskade enantiomerer av a-aminosyror kan framställas genom hydrering av den lämpligt ß-substituerade a-acylamido- 40 r akrylsyran på i förevarande sammanhang angivet sätt åtföljd '10 15 20 25 50 55 M 790=0351v7 av avlägsnandet av acylgruppen på a-aminogruppen och de andra skyddande-grupperna på konventionellt sätt, så att man erhåller den önskade enantiomeren.This is time consuming and expensive. The catalyst according to the invention enables the production of optically active products, whereby said time-consuming and expensive separation is eliminated at the same time as the yields of the desired enantiomers are increased and the amount of undesired enantiomer is reduced. Desired enantiomers of α-amino acids can be prepared by hydrogenating the appropriately β-substituted α-acylamidoacrylic acid in the manner set forth herein followed by the removal of the acyl group on the α-amino group and the other protecting groups in a conventional manner, so as to obtain the desired enantiomer.
Det har nu visat sig, att a-aminosyror framställda av 'de ß-substituerade a-acylamidoakrylsyrorna och/eller salter därav lätt kan framställas med stor övervikt av den önskade enantiomeren, vilket gör att katalysatorn enligt förevarande uppfinning är speciellt värdefull.It has now been found that α-amino acids prepared from the β-substituted α-acylamidoacrylic acids and / or salts thereof can be readily prepared with a large predominance of the desired enantiomer, which makes the catalyst of the present invention particularly valuable.
I följande exempel visas i närmare detalj hur hydreringen med katalysatorn enligt uppfinningen genomföres, men givetvis är uppfinningen icke begränsad till dessa detaljer. Med "delar" avses viktdelar, därest annat icke uttryckligen angives. I exemplen har % optisk renhet bestämts med följande ekvation (de optiska aktiviteterna är givetvis uttryckta som de speci- fika vridningarna, vilka bestämts-i ett och samma lösnings- mede1)= observerad optisk aktivitet för blandningen X 400 % optisk = renhet optisk aktivitet av den rena enantiomeren Exempel 1: De optiskt aktiva fosfinerna och arsinerna kan framställas på det sätt, som beskrives av Mislow och Kcrpium, J. Am. Chem. Soc., 89, 4784 (1967). ._ 121119012 + 2 cušon Ph P(oc1¶5)2 I ett lämpligt kärl utrustat med omrörare, temperatur- mätningsancrdning och beskicktningsanordning satsades 250 delar fenyldiklorfosfin, 240 delar pyridin och 495 delar hexan. Iösningen kyldes till ungefär 5-40°C och en blandning bestående av 96 delar metanol och 27 delar hexan tillsattes under omrörning under loppet av cirka 1,5 timmar. Den så erhållna blandningen omrördes under ytterligare 2,5 timmar medan den uppvärmdes till ungefär 25°C.-Reaktionen genom- fördes í inert kväveatmosfär. ïyridinhydroklorid, som bildades under reaktionen, avfiltrerades och filtratet konoentrerades. Den gula åter- stoden destillerades, man uppsamlade en färglös fraktion med destillationsintervall 95,5-97°C/47 mm Hg (82 % utbyte av dimetylfenylfosfonit). (Harwood and Grisley J. Am. Chem.The following examples show in more detail how the hydrogenation with the catalyst according to the invention is carried out, but of course the invention is not limited to these details. "Parts" means parts by weight, unless otherwise expressly stated. In the examples,% optical purity has been determined by the following equation (the optical activities are of course expressed as the specific rotations, which are determined in one and the same solvent1) = observed optical activity for the mixture X 400% optical = purity optical activity of the pure enantiomer Example 1: The optically active phosphines and arsines can be prepared in the manner described by Mislow and Krpium, J. Am. Chem. Soc., 89, 4784 (1967). ._ 121119012 + 2 cušon Ph P (oc1¶5) 2 In a suitable vessel equipped with a stirrer, temperature measuring device and loading device, 250 parts of phenyldichlorophosphine, 240 parts of pyridine and 495 parts of hexane were charged. The solution was cooled to about 5-40 ° C and a mixture of 96 parts of methanol and 27 parts of hexane was added with stirring over about 1.5 hours. The mixture thus obtained was stirred for a further 2.5 hours while heating to about 25 ° C. The reaction was carried out in an inert nitrogen atmosphere. The pyridine hydrochloride formed during the reaction was filtered off and the filtrate was concentrated. The yellow residue was distilled, collecting a colorless fraction with a distillation range of 95.5-97 ° C / 47 mm Hg (82% yield of dimethylphenylphosphonite). (Harwood and Grisley J. Am. Chem.
Soc., 82, 425 (1960)). O + cn I ----> Pníå-ocn Ph1=(ocH5)2 5 I 5 7900354-vi 40 15 20 25 50 12_ I ett_1ämplígt kärl utrustat med omrörare, temperatur- mätningsanordning och beskíoktningsanordning satsades 14 delar dímetylfenylfosfonit, 2,5 delar metyljodid och 9 delar ~ toluen. Den så erhållna lösningen upphettades långsamt.Soc., 82, 425 (1960)). O + cn I ----> Pniå-ocn Ph1 = (ocH5) 2 5 I 5 7900354-vi 40 15 20 25 50 12_ In a suitable vessel equipped with stirrer, temperature measuring device and coating device, 14 parts of dimethylphenylphosphonite, 2.5 parts were charged. parts methyl iodide and 9 parts ~ toluene. The solution thus obtained was slowly heated.
Reaktionen var exntermisk och temperaturen steg till cirka 440°C. Reaktionsblandningen hölls vid en temperatur av unge- fär 100-120°C och ytterligare 185 delar dímetylfenylfosfonit tillsattes långsamt. Ytterligare mängder metyljeaia i per- tioner om ungefär 1 del vardera tillsattes tid efter annan under fosfonittillsatsen. Reaktionsblandningen hölls vid ungefär 410°C under ytterligare 1 timme, sedan komponen- terna tillsatts. Reaktionsblandningen destillerades där- efter och man uppsamlade en portion med destillationsinter- vall tis-fxiurc/fv; mm Hg,- (96 % utbyte av metylfenylmetylfes- finat). (Harwood and Grisley J. Am. Chem. Soo., 82, 425 p(49eo)), GH; 9 cflš O \ + Pcl5 ----e >P - cl p///, P-OCH; Ph Ph_ I ett lämpligt kärl utrustat med omrörare, kondensor, temperaturmätningsanordning och beskíoktningsanordning satsades 187 delar metylfenylmetylfosfinat och 1600 delar koltetraklorid. Till denna blandning sattes 229 delar fos- forpentaklorid i tre portioner om vardera 50 delar och en portion om 79 delar. En temperaturstegring observerades vid tillsatsen av de tre första portionerna. Blandníngen omrör- des vid ungefär 60°C under två timmar ooh därefter avdestil- lerades koltetrakloriden och fosforoxikloriden. Ãterstoden destillerades och man uppsamlade en fraktion med destilla- tionsintervall 158-441°C/47 mm Hg. (95 % utbyte av metyl-5 fenylfosfinklorid). (Methoden Der-Organishen Chemie (Houben- weyl) vel. XII/I p. 243.) ' i ca C 5 CH? 9 . 5 Q bas CH5\\9 /\I> -cl + ?'_> :PÜ-o' Ph p I OH Ph CH //CHÉ\ cH“/ GH CH5 on; 5 _ 5 5 10 45 20 25 ÉO 45 vsoossa-7 I ett lämpligt kärl utrustat med omrörare, kondensor, temperaturmätningsanordning och beskicktningsanordning satsades 78 delar ut-mentol (få/%5 = -50° i etanol) och 72 delar dietyleter. Till den så erhällna lösningen sattes 449 delar trietylamin och blandningen kyldes till ungefär 0°C. Till blandningen sattes under omrörning 87 delar metyl- fenylfosfinklorid under loppet av ungefär 4,5 timmar medan temperaturen hölls vid ungefärhÖ°C. Blandningen fick sta. till dess att temperaturen stigit till ungefär 25 °C, varpå den upphettades under återflöde under ungefär 10,5 timmar.The reaction was extermic and the temperature rose to about 440 ° C. The reaction mixture was kept at a temperature of about 100-120 ° C and an additional 185 parts of dimethylphenylphosphonite was added slowly. Additional amounts of methylene oil in portions of about 1 part each were added time after time during the phosphonite addition. The reaction mixture was kept at about 410 ° C for an additional 1 hour after the components were added. The reaction mixture was then distilled and a portion was collected at distillation intervals tis-fxiurc / fv; mm Hg, - (96% yield of methylphenylmethylphosphinate). (Harwood and Grisley J. Am. Chem. Soo., 82, 425 p (49eo)), GH; 9 c fl š O \ + Pcl5 ---- e> P - cl p ///, P-OCH; Ph Ph_ In a suitable vessel equipped with a stirrer, condenser, temperature measuring device and coating device, 187 parts of methylphenylmethylphosphinate and 1600 parts of carbon tetrachloride were charged. To this mixture was added 229 parts of phosphorus pentachloride in three portions of 50 parts each and one portion of 79 parts. An increase in temperature was observed with the addition of the first three portions. The mixture was stirred at about 60 ° C for two hours and then the carbon tetrachloride and phosphorus oxychloride were distilled off. The residue was distilled and a fraction with a distillation range of 158-441 ° C / 47 mm Hg was collected. (95% yield of methylphenylphosphine chloride). (Methods Der-Organishen Chemie (Houben- weyl) vel. XII / I p. 243.) 'i ca C 5 CH? 9. 5 Q bas CH5 \\ 9 / \ I> -cl +? '_>: PÜ-o' Ph p I OH Ph CH // CHÉ \ cH “/ GH CH5 on; In a suitable vessel equipped with a stirrer, condenser, temperature measuring device and loading device, 78 parts of menthol (few /% 5 = -50 ° in ethanol) and 72 parts of diethyl ether were charged. To the solution thus obtained was added 449 parts of triethylamine and the mixture was cooled to about 0 ° C. To the mixture was added with stirring 87 parts of methylphenylphosphine chloride over the course of about 4.5 hours while maintaining the temperature at about 0 ° C. The mixture was allowed to stand. until the temperature rose to about 25 ° C, after which it was heated under reflux for about 10.5 hours.
Trietylaminhydrokloriden avfiltrerades från blandningen och filtratet koncentrerades, Härvid erhölls en fast substans, som smälte vid 50-6S°C och som visade sig vara en blandning av .1-mentylmetylfenylfosfinat-diastereoisomerer (60 % S och 40 % R).The triethylamine hydrochloride was filtered off from the mixture and the filtrate was concentrated to give a solid which melted at 50-6S ° C and which was found to be a mixture of .1-menthylmethylphenylphosphinate diastereoisomers (60% S and 40% R).
Den på ovan angivet sätt framställda blandningen av Ål-mentyl-metylfenylfosfinat-diastereoisomerer uppdelades i sina komponenter genom kristallisaticn flera gånger i hexan och kristallisation i dietyleter och man erhöll en fast subs- tans, som smälte vid 78-82°C och som visade sig vara S-formen av'.Q-mentyl-metylfenylfosfinat.The mixture of Al-menthyl-methylphenylphosphinate diastereoisomers prepared as above was partitioned between the components by crystallization several times in hexane and crystallization in diethyl ether to give a solid, melting at 78-82 ° C and showing be the S-form of'.Q-mentyl-methylphenylphosphinate.
CH 5 - o o Ph n ' Ph u Érxlo g + caöcfizcflamgs; \P*Û -cazcazcfiš GH; i 0:13 /°H\ ena en; I ett lämpligt kärl utrustat med en omrörare, en tem- peraturmätningsanordning, en beskioktningsanordning och en kondensor_inblástes en inert kväveatmosfär och därefter satsades 9,5 delar magnesium, 7 delar dietyleter och en reaktionsinitierande mängd jod. En liten mängd brompropan tillsattes för att initiera reaktionen, varpå en blandning bestående av 4? delar brompropan och 125 delar dietyleter långsamt tillsattes med en sådan hastighet, att mild åter- flödeskokning av reaktionsblandningen upprätthölls. Reak- tionsblandningen kyldes därefter till ungefär 25°C och om- rördes under ytterligare två timmar. i vaoorfisla-i? g 1.4 'IO '15 20 25 50 55 _ Till denna blandning sattes en blandning bestående av 12 delar av S-form av -Å-mentyl-metylfenylfosfinat (fram- ställt på ovan angivet sätt) och 88 delar bensen. Dietyl- etern avlägsnades därefter och den så erhållna blandningen upphettades vid 78°C under 64 timmar.CH 5 - o o Ph n 'Ph u Érxlo g + caöc fi zc fl amgs; \ P * Û -cazcazc fi š GH; at 0:13 / ° H \ ena en; In a suitable vessel equipped with a stirrer, a temperature measuring device, a coating device and a condenser, an inert nitrogen atmosphere was blown in and then 9.5 parts of magnesium, 7 parts of diethyl ether and a reaction-initiating amount of iodine were charged. A small amount of bromopropane was added to initiate the reaction, whereupon a mixture consisting of 4? parts of bromopropane and 125 parts of diethyl ether were slowly added at such a rate that mild refluxing of the reaction mixture was maintained. The reaction mixture was then cooled to about 25 ° C and stirred for an additional two hours. i vaoor fi sla-i? g 1.4 'IO '15 20 25 50 55 _ To this mixture was added a mixture consisting of 12 parts of S-form of -α-menthyl-methylphenylphosphinate (prepared as above) and 88 parts of benzene. The diethyl ether was then removed and the mixture thus obtained was heated at 78 ° C for 64 hours.
Magnesiumkomplexreaktionsprodukten sönderdelades med en_lösning av ammoniumklorid och filtrerades därefter. Fäll- ningen extraherades med het bensen och extraktet kombinerades med filtratetÅ Det organiska skiktet torkades över natrium- sulfat och lösningsmedlen avlägsnades, varigenom man erhöll en gul olja. Denna kromatograferades på en kiseldioxidgel- kolonn.men en blandning av hexanzbensenzdietyleter (5:1:4), varigenom man erhöll en optiskt aktiv fenylmetylpropylfos- finoxid i 61 % utbyte.The magnesium complex reaction product was decomposed with a solution of ammonium chloride and then filtered. The precipitate was extracted with hot benzene and the extract was combined with the filtrate. The organic layer was dried over sodium sulfate and the solvents were removed to give a yellow oil. This was chromatographed on a silica gel column to give a mixture of hexanesbenzene diethyl ether (5: 1: 4) to give an optically active phenylmethylpropylphosphine oxide in 61% yield.
Ph- . u a 5 Ph _ D) . \\ )' //, P* -CH2-cH2-CH; + Hslclš + Ef5N'---+> .-cH2cH2cH5 cnš. e g CH5 I ett lämpligt kärl, som beskickats med en inert kväve- atmosfär och som var utrustat med omrörare, temperaturmät- g ningsanordning och beskicktningsanordning, satsades 16 delar triklorsilan och 88 delar bensen vid en temperatur av iungefär OfC. Till denna blandning sattes vid en temperatur av ungefär 4~6°C en blandning bestående av 22 delar trietyl- gamin och 44 delar bensen. Den så erhållna blandningen värmdes därefter till ungefär 25°0 och en blandning av 8,2 delar optisht aktiv fenylmetylpropylfosfinoxid (som framställts på ovan angivet sätt) och 22 delar bensen tillsattes. Blandning- en upphettades därefter till ungefär 60°C under loppet av tvâ timmar och kyldes därefter till ungefär 2590-.Ph-. u a 5 Ph _ D). \\) '//, P * -CH2-cH2-CH; + Hslclš + Ef5N '--- +>.-CH2cH2cH5 cnš. e g CH5 In a suitable vessel, which was charged with an inert nitrogen atmosphere and which was equipped with a stirrer, temperature measuring device and loading device, 16 parts of trichlorosilane and 88 parts of benzene were charged at a temperature of approximately OfC. To this mixture was added at a temperature of about 4-6 ° C a mixture consisting of 22 parts of triethylamine and 44 parts of benzene. The mixture thus obtained was then heated to about 25 DEG C. and a mixture of 8.2 parts of optically active phenylmethylpropylphosphine oxide (prepared as above) and 22 parts of benzene were added. The mixture was then heated to about 60 ° C over two hours and then cooled to about 2590 ° C.
Det-som reaktionsprodukt erhållna kiselkomplexèt sönder- ' delades med 75 delar av en 20 % lösning av natriumhydroxid och därefter med 55 delar vatten. Den så erhållna blandningen fick stå ungefär 45 timmar, varpå den uppdelade sig.i skikt, 'iDet organiska skiktet extraherades med 5 % saltsyra, två gånger med vatten och torkades därefter över natriumsulfat.The silicon complex obtained as a reaction product was decomposed with 75 parts of a 20% solution of sodium hydroxide and then with 55 parts of water. The mixture thus obtained was allowed to stand for about 45 hours, after which it was divided into layers. The organic layer was extracted with 5% hydrochloric acid, twice with water and then dried over sodium sulfate.
Iösningsmedlet avdestillerades och man erhöll metylpropyl- fenylfosfin i 95 % utbyte med 69 % optisk renhet. 10 45 20 25 50 15 7900 354 '7 Ett sätt att framställa r°<1ium(III)k10rid-tris- (metyl-propylíenylfosfin) beskrivas här nedan.The solvent was distilled off to give methyl propylphenylphosphine in 95% yield with 69% optical purity. 10 45 20 25 50 15 7900 354 '7 A process for producing r <<1ium (III) chloride-tris- (methyl-propylenylphosphine) is described below.
Ett lämpligt kärl innehållande kväveatmosfär be- skickaaes med 0,542 g (o,oo15 mal) roaiuumïïïnaoria- ' _ trihydrat och 10 ml metanol, varpå 0,76 g (0,0046 mol) av det på ovan angivet sätt framställda, optiskt aktiva metyl- propylfenylfosfinet i 5 ml metanol tillsattes droppvis under loppet av 15 minuter. Blandningen fick stå i en timme, varunder en gul fällning bildades. Denna avfiltrerades och man erhöll 0,21 g av rodiumkomplexet med specifik vridning [@7å5 = -69,2° (en blandning av bensen och etanol i volym- förhållandet 1:1). _ Genom koncentration av fíltratet erhölls ytterligare 0,15 g av produkten med specifik vridning [5]å5 = -56,4° (en blandning av bensen och etanol i volymförhàllandet 1:1).A suitable vessel containing a nitrogen atmosphere is charged with 0.542 g (10,000 ml) of hydrochloric acid trihydrate and 10 ml of methanol, followed by 0.76 g (0.0046 mol) of the optically active methyl acetate prepared as above. The propylphenylphosphine in 5 ml of methanol was added dropwise over 15 minutes. The mixture was allowed to stand for one hour, during which time a yellow precipitate formed. This was filtered off to give 0.21 g of the rhodium complex with specific rotation [α] 25 = -69.2 ° (a mixture of benzene and ethanol in a volume ratio of 1: 1). Concentration of the filtrate gave an additional 0.15 g of the product with specific rotation [5] å5 = -56.4 ° (a mixture of benzene and ethanol in a volume ratio of 1: 1).
Exempel 2: Det i exempel 1 beskrivna allmänna förfarandet upprepades och blandningen av «¿-mentyl-metylfenylfosfinat- diastereoisomererna spaltades genom kristallisation i hexan och/eller hexaneter, varigenom man erhöll en S-form, som smälte vid 78-82°C och hade specifik vridning Åälås = -94° (bensen) och en R-form, som smälte vid 86-87°C och hade specifik vridning [Q/äs = -17°(bensen). 0:15 ocnš I o ngar O Ph .I-pßr) _. od-É l ___:h\;>r)@ .cíïâø /CH\ os; o cH5 H5 ' CHE/ I ett lämpligt kärl utrustat med omrörare, temperatur- mätningsanordning, beskicktningsanordning och kondensor in- blåstes en inert kväveatmosfär, varpå man satsade 18,5 delar magnesiumsvarvspån, 14 delar dietyleter och en reaktionsinit- ierande mängd jodl En liten mängd o-anisylbromid tillsattes för initiering av reaktionen och därpå tillsattes långsamt en blandning av 158 delar o-bromanisol och 400 delar dietyl- eter med sådan hastighet, att mild återflödeskokning upprätt- hölls. Sedan tíllsatsen tillförts kokades blandningen under återflöde ytterligare två timmar. 0 7900354'7 10 15 20 25 §O 55 'IG Till blandningen sattes en blandning bestående av 74 delar av antingen R- eller S-formen av 1L-mentyl-metylfenyl- fosfinat (val av S- eller R-formen beror på vilken enantiomer som önskas erhållen genom den asymetriska hydreringen) och 450 delar bensen. Dietyletern avlägsnades därefter och bland- ningen uppnettedee vid 7a°c under 64 timmer.Example 2: The general procedure described in Example 1 was repeated and the mixture of the β-menthyl-methylphenylphosphinate diastereoisomers was cleaved by crystallization from hexane and / or hexane ethers to give an S-form, melting at 78-82 ° C and having specific rotation Åälås = -94 ° (benzene) and an R-shape, which melted at 86-87 ° C and had specific rotation [Q / äs = -17 ° (benzene). 0:15 ocnš I o ngar O Ph .I-pßr) _. od-É l ___: h \;> r) @ .cíïâø / CH \ os; o cH5 H5 'CHE / In a suitable vessel equipped with a stirrer, temperature measuring device, loading device and condenser an inert nitrogen atmosphere was blown in, whereupon 18.5 parts of magnesium turnings, 14 parts of diethyl ether and a reaction-initiating amount of iodine were charged. o-Anisyl bromide was added to initiate the reaction, and then a mixture of 158 parts of o-bromoanisole and 400 parts of diethyl ether was slowly added at such a rate that mild reflux boiling was maintained. After the addition was added, the mixture was refluxed for a further two hours. § 79 55 'IG To the mixture was added a mixture consisting of 74 parts of either the R- or S-form of 1L-menthyl-methylphenylphosphinate (choice of the S- or R-form depends on which enantiomer desired to be obtained by the asymmetric hydrogenation) and 450 parts of benzene. The diethyl ether was then removed and the mixture was stirred at 7 ° C for 64 hours.
Det som reaktionsprodukt erhållna magnesiumkomplexet sönderdelades med en lösning av ammoniumklorid och produkten extraherades ur vattenfasen med bensen. Sedan bensenen av- lägsnats destillerades den som återstod erhållna oljan, var- vid man först avlägsnade en mentolfraktion. Slutligen destil- ienedee produkten över vid 180-19o°c/0,5 nn Hg. Den need metylfenyl-o-anisylfosfinoxiden bildades i 60 % utbyte. Vid användning av R-formen erhölls en produkt med specifik. vridning [Q]š5= +27°(metanol). Did användning av S-formen erhölls en produkt med motsatt vridning.The magnesium complex obtained as a reaction product was decomposed with a solution of ammonium chloride and the product was extracted from the aqueous phase with benzene. After the benzene was removed, the remaining oil was distilled, first removing a menthol fraction. Finally, distill the product over at 180 DEG-19 DEG C./0.5 nm Hg. The required methylphenyl-o-anisylphosphine oxide was formed in 60% yield. Using the R-form, a product with specific was obtained. rotation [Q] š5 = + 27 ° (methanol). Using the S-shape, a product with opposite rotation was obtained.
CH O p-d 9 ocnš ' Ph 7 #5 rn - ex) + Hsici + Et N_--_; \\\rX) - /f 5 5 // - CH; _ cs; .CH O p-d 9 ocnš 'Ph 7 # 5 rn - ex) + Hsici + Et N _ - _; \\\ rX) - / f 5 5 // - CH; _ cs; .
I ett lämpligt kärl innehållande inert kväveatmosfär och utrustat med omrörare, temperaturmätningsanordning och beskicktningsanordning satsades 46 delar triklorsilan och A 400 delar bensen vid en temperatur av ungefär 5°C, Till blandningen sattes vid 4-6°C en blandning av 42 delar tri- etylamin och 50 delar bensen. Den så erhållna blandningen uppvänndee.ti11 7o°c een en blandning av 7,5 delen optisk: aktiv metylfenyl-o-anisylfosfinoxid i 50 delar bensen till- sattes. Blandningen upphettades till 70 °G under 1 timme och kyldes därefter till 25°c. D -Det som reaktionsprodukt erhållna kiselkomplexet sönder- delades genom tillsats under kväve av 75 delar av en 20 % natriumhydroxidlösning vid 25°C under kylning. Det önskade metylfenyl-o-anisylfosfinet erhölls ur det organiska skiktet.In a suitable vessel containing an inert nitrogen atmosphere and equipped with a stirrer, temperature measuring device and loading device, 46 parts of trichlorosilane and A 400 parts of benzene were charged at a temperature of about 5 ° C. To the mixture was added at 4-6 ° C a mixture of 42 parts of triethylamine and 50 parts of benzene. The mixture thus obtained was stirred at 70 DEG C. and a mixture of 7.5 parts of optically active methylphenyl-o-anisylphosphine oxide in 50 parts of benzene was added. The mixture was heated to 70 ° C for 1 hour and then cooled to 25 ° C. D -The silicon complex obtained as a reaction product was decomposed by adding under nitrogen 75 parts of a 20% sodium hydroxide solution at 25 ° C under cooling. The desired methylphenyl-o-anisylphosphine was obtained from the organic layer.
Det hade specifik vridning [Q/š5= +4¶° (metanol§ när den på ovan angivet sätt framställda fosfinoxiden med specifik vridning lå/%5= +27° (metanol) användes. Vid användning av den motsatta enantiomeren av fosfinoxiden erhölls fosfin med motsatt vridning. D 40 45 20 25 50 55 7900351» ' 7 47 Exempel_5: Framställning av metylcyklohexyl-o-anisjlfosfin O OCH OCH .. 5 0 ) 5% ah/c " ) Wo ---» 9:33 CH; 3 En enlíters autoklav beskickades med 445 delar av den på ovan angivet sätt framställda (+)-mety1feny1-o-anisyl- fosfinoxiden, 28 delar 5 % rodium på kol och 250 delar metanol. Satsen upphettades till 75°C och omrördes under en väteatmosfär med ett tryck av 56 kp/cm? övertrïtk. Nar väte- upptagníngen upphörde visade NMB-spektrum att den i den ovan återgivna ekvationen beskrivna reaktionen försiggätt till 75 %. En ytterligare mängd om 7,0 delar katalysator till- sattes, satsen sattes åter igen under vätgastryck 56 kp/cma övertryok och reaktionen fortsattes till en omsättning av 96 %. Katalysatorn avfíltrerades och metanolen avdrevs under vakuum. Den råa oljan upptogs i 200 delar dibutyleter och kyldes till O°C. Kristallerna som utföll avfiltrerades och tvättades med hexan. Man erhöll på detta sätt 65 delar metyl- cyklohexyl-o-anisylfosfinoxid, som smälte vid 408-140°C och hade specifik vridning [Q]šO= +65° (metanol).It had specific rotation [Q / š5 = + 4¶ ° (methanol§ when the phosphine oxide with specific rotation prepared above was /% 5 = + 27 ° (methanol) was used. Using the opposite enantiomer of the phosphine oxide, phosphine was obtained with reverse rotation. D 40 45 20 25 50 55 7900351 »'7 47 Example_5: Preparation of methylcyclohexyl-o-anisylphosphine AND AND .. 5 0) 5% ah / c") Wo --- »9:33 CH; A one liter autoclave was charged with 445 parts of the (+) - methylphenyl-o-anisylphosphine oxide prepared as above, 28 parts of 5% rhodium on carbon and 250 parts of methanol, the batch was heated to 75 ° C and stirred under a hydrogen atmosphere When the hydrogen uptake ceased, the NMB spectrum showed that the reaction described in the above equation proceeded to 75%. An additional 7.0 parts of catalyst was added, the batch was added again again under hydrogen pressure 56 kp / cma overpressure and the reaction was continued to a conversion of 96%. was filtered off and the methanol was evaporated in vacuo. The crude oil was taken up in 200 parts of dibutyl ether and cooled to 0 ° C. The precipitated crystals were filtered off and washed with hexane. 65 parts of methylcyclohexyl-o-anisylphosphine oxide were obtained in this way, which melted at 408-140 ° C and had a specific rotation [Q] O = + 65 ° (methanol).
Den på ovan angivet sätt framställda fosfinoxiden kan reduceras till metylcyklohexyl-o-anisylfosfin i 95 % utbyte med användning av HSiCl och trietylamin på sätt som angives här ovan för metylfenyl-o-anisylfosfin. Det erhållna metyl- cyklohexyl-o~anisylfosfinet är en vätska med specifik vrid- ning Z@7šo= +98,5° (metanol).The phosphine oxide prepared as above can be reduced to methylcyclohexyl-o-anisylphosphine in 95% yield using HSiCl and triethylamine in the manner set forth above for methylphenyl-o-anisylphosphine. The resulting methylcyclohexyl-o-anisylphosphine is a liquid with specific rotation Z @ 7šo = + 98.5 ° (methanol).
Asymmetrisk hydreríng av a-bensamido-4-hydroxi- 5-metoxi-kanelsyra En hydreringsapparat utrustad med tryckmätare, tempera turmätníngsanordning och upphettningsanordning beskickades med 25 delar a-bensamido-4-hydroxi-5-metoxi-kanelsyra, 186 delar metanol och 64 delar 5 % natriumhydroxid. Satsen ren- blåstes omsorgsfullt för avlägsnande av varje spår av luft och vätgastrycket inställdes slutligen på 3,5 kp/cm? över- tryck och temperaturen på 25°C.Asymmetric hydrogenation of α-benzamido-4-hydroxy-5-methoxy-cinnamic acid A hydrogenation apparatus equipped with a pressure gauge, temperature measuring device and heating device was charged with 25 parts of α-benzamido-4-hydroxy-5-methoxy-cinnamic acid, 186 parts of methanol and 64 parts 5% sodium hydroxide. The batch was carefully blown clean to remove each trace of air and the hydrogen pressure was finally set at 3.5 kp / cm? overpressure and the temperature of 25 ° C.
En katalysatorlösning framställdes genom upplösning av 0.0059 s rodium-4,5-Hexadiankloria (¿âh(1,5-hexaeian)o;7¿) med smältpunkt 415-447°C, Exempel 4: 47900354-vi 40 45 20' 25 50 55 48 elementaranalysfi % C % H g % Cl barnmat 52,68 4,57 i 16,08 funnet ~ §2,41 4,44 45,82 u." Am. cham. saa., 86,217 (1964)) i 2 m1 banaen under kväveatmosfär. Därefter tillsattes 0,0159 g (+)-metylfenyl- o-anisylfosfin,_[&]š5= +42° (metanol) i 1,5 ml bensen.A catalyst solution was prepared by dissolving 0.0059 s of rhodium-4,5-Hexadianchloria (δ âh (1,5-hexaeian) o; 7¿) with melting point 415-447 ° C, Example 4: 47900354-vi 40 45 20 '25 50 55 48 elemental analysis fi% C% H g% Cl baby food 52.68 4.57 in 16.08 found ~ §2.41 4.44 45.82 u. "Am. Cham. Saa., 86.217 (1964)) i 2 Then, 0.0159 g of (+) - methylphenyl-o-anisylphosphine was added, _ [&] š5 = + 42 ° (methanol) in 1.5 ml of benzene.
Faafinaxiaföratagat nada en amäitpuakt av 7o-75°c, e (/d]åP= +25,9° (metanol)). Därpå leddes väte genom bland- ningen under fem minuter. Den så erhållna katalysatorlös- 'ningen_inpressades därefter_i en autoklav med vätetryck.Faafinaxia is carried out without an amide pact of 70-75 ° C, e (/ d] åP = + 25.9 ° (methanol)). Hydrogen was then passed through the mixture for five minutes. The catalyst solution thus obtained was then pressed into an autoclave with hydrogen pressure.
Hydreringen började omedelbart och var avslutad efter 5-4 grimmar vid 25°c och 5,5 kp/cmg övar-tryck.The hydrogenation started immediately and was completed after 5-4 halters at 25 ° C and 5.5 kp / cmg overpressure.
Analys av den så erhållna lösningen visade en optisk renhet av 56,4 % svarande mot en I/D#blandning av natriumf saltet av Nlbensoyl-5-(4-hydroxi-5-metoxifenyl)-alanin i mängdförhållandet 78:22. ' l l Den-N>bensoylsubstiterade aminosyran kan framställas i 95 % utbyte genom förângning av metanolen ooh neutralisa- tion av natriumsaltet med saltsyra. _ Den så erhållna Ifenantíomeren kan omvandlas till IFDOPA genom enkel hydrolys för avlägsnande av de blockerande grup- perna bensoyl och metyl på substituenten i 5-ställningen på fenylgruppen.Analysis of the solution thus obtained showed an optical purity of 56.4% corresponding to an I / D # mixture of the sodium salt of N1benzoyl-5- (4-hydroxy-5-methoxyphenyl) -alanine in a ratio of 78:22. The benzoyl-substituted amino acid can be prepared in 95% yield by evaporation of the methanol and neutralization of the sodium salt with hydrochloric acid. The Ifenantiomer thus obtained can be converted to IFDOPA by simple hydrolysis to remove the blocking groups benzoyl and methyl on the substituent in the 5-position of the phenyl group.
Exemgel §: En enlíters autoklav teskickades med 25,0 g af bensamido-4-hydroxi-5~metoxí-kanelsyra, 500 ml metanol och .O,6 mlo5 % vattenlösning av NaOH. Satsen omrördes vid 25°C under 2,8 kp/cm? (övertryck) av ren vätgas, till dess att det med säkerhet kunde konstateras att ingen läckning före- kom. Ungefär 1 ml (0,01 % Rh, 0,05 % fosfin) av följande lkatalysatorlösning tillsattes genom en skiljevägg utan att trycket_avblåstes. Katalysatorlösningen hade framställts genom upplösning under Nä av 0,005O g [Fb (4,5-hexadien)0l7 , smältpunkt 145-417°C, elementaranalysz %.C % H % Cl beräknat 52,681 4,§7 46,08 funnet 32,44 4,41 g 45,82 i 0,35 ml av_en lösning av metylfenyl-o-anisylfosfin l/d/â5= +42° (metanol) med specifik vridning /Ä/%5= +42° e (metanol) i bensen innehållande 0,041 g/ml och utspädning 40 45 7900354 '-7 49 till 4 ml med metanol. Fosfinoxidförsteget hade en smält- punkt av 70-75°C, ([Q]%0= +25,9° (metanol).Example Gel: A one liter autoclave was sent with 25.0 g of benzamido-4-hydroxy-5-methoxy-cinnamic acid, 500 ml of methanol and 0.6 ml of 5% aqueous NaOH. The batch was stirred at 25 ° C below 2.8 kp / cm (overpressure) of pure hydrogen gas, until it could be established with certainty that no leakage occurred. Approximately 1 ml (0.01% Rh, 0.05% phosphine) of the following catalyst solution was added through a partition without depressurizing the pressure. The catalyst solution had been prepared by dissolving under Na of 0.0050 g [Fb (4,5-hexadiene) 017, melting point 145-417 ° C, elemental analysis% .C% H% Cl calculated 52.681 4, §7 46.08 found 32.44 4.41 g 45.82 in 0.35 ml of a solution of methylphenyl-o-anisylphosphine l / d / â = = 42 ° (methanol) with specific rotation / Ä /% 5 = + 42 ° e (methanol) in benzene containing 0.041 g / ml and diluting to 49 ml with methanol. The phosphine oxide precursor had a melting point of 70-75 ° C, ([Q]% 0 = + 25.9 ° (methanol).
Omrörning med 4400 varv per minut upprätthölls i reaktionsmassan ooh väte började absorberas efter 2-5 minuters induktionstid. Hydreringen var slutförd på 2 timmar.Stirring at 4400 rpm was maintained in the reaction mass and hydrogen began to be absorbed after 2-5 minutes of induction time. The hydrogenation was completed in 2 hours.
Metanolen avdrevs ooh syran löstes i en mol av en vattenlösning av NaOH. Den neutrala katalysatorn extra- herades med bensen och ställdes undan för utvinning. Den fria aminosyran fälldes därefter genom tillsats av kon- centrerad H01 under riklig ympning. Man erhöll 24 g N- bensoyl-fi-(Lx-hydroxi-ä-metoxirenyn-alanin innehållande 75 % av I-enantiomeren och 2? % av D-enantiomeren. I- enantiomeren kan omvandlas till IFDOPA genom hydrolys på sätt som.angives i exempel 4.The methanol was evaporated and the acid was dissolved in one mole of an aqueous solution of NaOH. The neutral catalyst was extracted with benzene and set aside for recovery. The free amino acid was then precipitated by the addition of concentrated H01 with copious inoculation. 24 g of N-benzoyl-(- (Lx-hydroxy-α-methoxirenynalanine were obtained containing 75% of the I-enantiomer and 2?% Of the D-enantiomer. The I-enantiomer can be converted to IFDOPA by hydrolysis as indicated in Example 4.
Exempel 6-21: Andra optiskt aktiva a-aminosyror framställ- des på sätt liknande dem som angives i exemplen 4 och 5 med användning av en katalysator innehållande rodium- 4,5-hexadienklorid och fosfinligand med strukturformeln /0115 R-PX Q Exemplen är sammanställda i nedanstående tabell: 20 7 9G035lr '7 mmu hmu.Examples 6-21: Other optically active α-amino acids were prepared in a manner similar to those set forth in Examples 4 and 5 using a catalyst containing rhodium-4,5-hexadiene chloride and phosphine ligand of the structural formula / 0115 R-PX Q The examples are compiled in the table below: 20 7 9G035lr '7 mmu hmu.
H.ñ¶H.QN.IO Ofln_v OHfl-u . _ . _ Û . mz. :z _ _ _ . _ _ _ wm mßloß .êñ o . . mooošoummu møoufunwmu EU 1 ¶ \ / _ onu ono _ _ o Qwwuww am .hmummummum .. mooolwuïmmu moonfioumzu , ¶ x _ 2%: “Tu _ .NEUAX . , ,. a .u._...š=wH. xfiuho uonsm 989% Éšöë :G30 . ._ .Emswxm ¶ . mmsnioomx :Hoëwmhflmpmm _ ¶ . "mvmø .må ¶ ¶ _ 79003-5-4-'7 21 Hßwfinmno ä “WR âw ¶ , ¶ m .moö 3 Qæwxww mm Rmummummu w Qwwlww å -Nmummummu & .vmflflmn o°mSw«a novmmhflmvøx xwflmo wmssšu a? "æumw .mmm ouu W _ , ímz \ / O H _ EZ _ _ w mooumu- mul® . »vn _ ._ mmu _ nu _ mz _ m :oonïmu :u . Ä x vxøflonm OHU _ . _.H.ñ¶H.QN.IO O fl n_v OH fl- u. _. _ Û. mz. : z _ _ _. _ _ _ wm mßloß .êñ o. . mooošoummu møoufunwmu EU 1 ¶ \ / _ onu ono _ _ o Qwwuww am .hmummummum .. mooolwuïmmu moon fi oumzu, ¶ x _ 2%: “Tu _ .NEUAX. ,,. a .u ._... š = wH. x fi uho uonsm 989% Size: G30. ._ .Emswxm ¶. mmsnioomx: Hoëwmh fl mpmm _ ¶. "mvmø .må ¶ ¶ _ 79003-5-4-'7 21 Hßw fi nmno ä“ WR âw ¶, ¶ m .moö 3 Qæwxww mm Rmummummu w Qwwlww å -Nmummummu & .vm flfl mn o ° mSw «a novmmh fl mvøm xw š? æumw .mmm ouu W _, ímz \ / OH _ EZ _ _ w mooumu- mul®. »Vn _ ._ mmu _ nu _ mz _ m: oonïmu: u. Ä x vxø fl onm OHU _. _.
IOOUÅVHEU mmu _ 0" _ _ mz » _ N _ moouÖu xu GfiuÖflO . i . i . . mooowöhwäoë moou|oumul® H ofi x _ Hwmëwxm '19oo¶zs4-A7 22 m.VH , m\mw|ww AM M . ¶ _ . _ _ w ¶ zøoufzu- .ÜIÛ _ . fix _ nmamfl .mh@. -mzomzu mo Hhmfiflmno 9 ¶ mv? eä Û . mmuö .IOOUÅVHEU mmu _ 0 "_ _ mz» _ N _ moouÖu xu G fi uÖ fl O. I. I... Mooowöhwäoë moou | oumul® H o fi x _ Hwmëwxm '19oo¶zs4-A7 22 m.VH, m \ mw | ww AM M. ¶ _. _ _ W ¶ zøoufzu- .ÜIÛ _. Fi x _ nmam fl .mh @. -Mzomzu mo Hhm fifl mno 9 ¶ mv? Eä Û. Mmuö.
R .voflflwn Oofism uovmmäamvmx xfipmo wmsašïmx :mmu _. nU. ._ EZ .m . moouáo.. mu|® AX _ PMSOOHA , _ 3 ~ . . :oou-onæu.l® 3 MID _ _ .R .vo flfl wn Oo fi sm uovmmäamvmx x fi pmo wmsašïmx: mmu _. now. ._ EZ .m. moouáo .. mu | ® AX _ PMSOOHA, _ 3 ~. . : oou-onæu.l® 3 MID _ _.
HU . _ f _ _ ,EZ _ _ . moouónmuü _ Ha _HwNEwXü_ CwWmfiO 7900351+ 'A7 25 Aflonmnmfiv flhflmn . ømóv., 13%? u %\fiN wmpmnwm _ _ .o èüflofiwwow.. _ Nm . . .^HofimßwEv 0% O+HÛN Q wm m\mw|wæ mä |mUNEUmIU R ,®wnfloH ommäw uovmmäwmemz xmflšo mmeaäïmx "mvmu .mßh II..HU. _ f _ _, EZ _ _. moouónmuü _ Ha _HwNEwXü_ CwWm fi O 7900351+ 'A7 25 A fl onmnm fi v fl h fl mn. ømóv., 13%? u% \ fi N wmpmnwm _ _ .o èü fl o fi wwow .. _ Nm. . . ^ Ho fi mßwEv 0% O + HÛN Q wm m \ mw | wæ mä | mUNEUmIU R, ®wn fl oH ommäw uovmmäwmemz xm fl šo mmeaäïmx "mvmu .mßh II ..
O" _ EZ _ moou|mu| AX _ EOOUIIU ^X -mmulmom O fl-.MDUO Hnfl Nnolwóm _ _ m O EU mao OH ._ _ EZ * , fiwwfim .O moouóumu .vw , ommu mao . _ EOOUIUHIU OI MH flwmñwäm 79GO3Eh'7 om 24 m\Q@ mg #ß«-m>« Qaw wwßmnwm _L@flx°qfiHmo« _OømEm_u wmasšv .ha ”øvæø .mmm whm@Hmomfi Hhuwvmwflwäum Hovmwhamvmx nu mz _ m moouåu- :u AX. ¶ O O _ M :ooošukmuuøl o: AK mao mao vå5UOHß . ouo. _ . d _ I m2 . _ _ ¶ . . moonïuuzu än 9,. 3 í. ¶ ommu > . fiwmflo. wmmawfxul 790Û35-lw7 \ '25 io .woášmv .E __ o _ _ %Honm%øEv _ .flhømw _m_ TLLQ ___fl _ J F _7æ2@ _. _ u _ m wfiomämw .èxovws ._ _ onu __ _ _ ouu _ mßnww aäm _ _ _ wwßmnmw EZ _ luwfloflfiumom :ooušußmmu o: :oooónmu om 3 _- /m Rx m _ _ m EU _ O EU O 30 . _ o" _ ._ _ . . . . _ nflødflovv _ ._ _ _ _ _ _ _ _ _ orw+nG%\M\ mä _ _ mä. _ w .b.3218 å -Nmvë moQYflQwmQIÛIoÉH mooflvónmblom _ .SH . _ . vn _ . . . ._ _ _ __ _ omxu ._ _ ommu _ .vmnflmn Oouflm _ Hovmmwamvmx väßfloum :wwmHO Hmmšwxw Mmïmo wmëåoäx "mpmw .whm _ _ _96 J _ _ _ Å __ _ __ \mmu Nm ü møoofmnvwmßïmo/ _ O” _ man m _ __ _ MO m % Hhwfinmno. ouw , Wb _ _ \o. _ _ ma. _ _ om SHR ma» _ moou|mwlwfimou®zo|wmmo _ en o ._ måne _ _ _ . _ oßní _ å .mßfoß man _ _ _ _ moonïmu-Nmolßøm. _ _ _ _ _ nn _. m .W _ mmo: _ _ . _ o mo .flfi & .@oxflmfi Uomëw flflmwwfl . __ ußæwowm .á äflpmo wmaašïå »nouåšmhvmw _ .nU_ "mvmu .mhm 0 _ _ _ 9 fl..O "_ EZ _ moou | mu | AX _ EOOUIIU ^ X -mmulmom O fl-. MDUO Hn fl Nnolwóm _ _ m O EU mao OH ._ _ EZ *, fi ww fi m .O moouóumu .vw, ommu mao. _ EOOUIUHIU OI MH fl wmñwäm 79GO3Eh'7 om 24 m \ Q @ mg # ß «-m>« Qaw wwßmnwm _L @ fl x ° q fi Hmo «_OømEm_u wmasšv .ha” øvæø .mmm whm @ Hmom fi Hhuwvmw fl wäum Hovmuham _m. OO _ M: ooošukmuuøl o: AK mao mao vå5UOHß. Ouo. _. D _ I m2. _ _ ¶.. Moonïuuzu än 9 ,. 3 í. ¶ ommu>. Fi wm fl o. Wmmawfxul 790Û35-lw7 \ '25 io .woášmv .E __ o _ _% Honm% øEv _ .fl hømw _m_ TLLQ ___ fl _ JF _7æ2 @ _. _ U _ m w fi omämw .èxovws ._ _ onu __ _ _ ouu _ mßnww aäm _ _ _ wwßmnmw EZ _ luw fl ošu umm: :: oooónmu om 3 _- / m Rx m _ _ m EU _ O EU O 30. _ o "_ ._ _. . . . _ n fl ød fl ovv _ ._ _ _ _ _ _ _ _ _ _ orw + nG% \ M \ mä _ _ mä. _ w .b.3218 å -Nmvë moQY fl QwmQIÛIoÉH moo fl vónmblom _ .SH. _. vn _. . . ._ _ _ __ _ omxu ._ _ ommu _ .vmn fl mn Oou fl m _ Hovmmwamvmx väß fl oum: wwmHO Hmmšwxw Mmïmo wmëåoäx "mpmw .whm _ _ _96 J _ _ _ Å __ _ __ \ mmu Nm ü møoofm _ __ _ MO m% Hhw fi nmno. Ouw, Wb _ _ \ o. _ _ Ma. _ _ Om SHR ma »_ moou | mwlw fi mou®zo | wmmo _ en o ._ måne _ _ _. _ Oßní _ å .mßfoß man _ _ _ _ moonïmu-Nmolßøm. _ _ _ _ _ nn _. m .W _ mmo: _ _. _ o mo .flfi &. @ ox fl m fi Uomëw flfl mww fl. __ ußæwowm .á ä fl pmo wmaašïå »nouåšmhvmw _ .nU_" mvmu .mhm 0 _ _ _ 9 fl ..
NZ _ .wooolwuflo Olwnmv ß _. en» ._ _ _ _ ma _ nu.. _. \\ moonïwumnïmnf. _ __ mun mao _ _ OIÜ \flO o cflw _ _ _. å _ _ moou|oflmol®o_m __ ammo. øfiïflo .rm Homemxm 10 15 20 25 50 55 7900354~? 27 En eueekiev beekiekedee med 25,0 g (o,0s5 mel) deaoetamido-4-hydroxi-5-metoxi-kanelsyraacetat, 500 ml metanol den 0,56 m1 50 % Neon. Adtekieven eettee under ett tryck av 2,46 kp/cm? övertryck med en blandning av N2 och H2 (50:50). _ 1 En katalysatorlösning framställdes genom upplösning av 0,o050 g (0,025 mekv.) ¿§h(4,5-hexedien)c;7ë 1 0,5 m1 beneen, varpå man under kväveatmosfär tillsatte 0,051 mekv. (+)- metyloyklohexyl-o-anisylfosfin (optisk renhet ca 90 %) i 2,4 ml bensen. Väte bubblades genom denna lösning under 10 minuter, Rhodium»1,5-hexadienklorid, se exempel 4 och 5 här Exempel 22: ovan. men erhöll på detta eat: (+)meey1eyk1enexy1-e-enieyl- feefin, vätekefermig, kekpunke 110-114°o/0,09 mena-/d7š°= +9s,5@ (e=« 1 meon) vid 90 %.epe1ek renhet ¿d/§°= +s9° (e=1 i MeOH).NZ _ .wooolwu fl o Olwnmv ß _. en »._ _ _ _ ma _ nu .. _. \\ moonïwumnïmnf. _ __ mun mao _ _ OIÜ \ fl O o c fl w _ _ _. å _ _ moou | o fl mol®o_m __ ammo. ø fi ï fl o .rm Homemxm 10 15 20 25 50 55 7900354 ~? 27 Eekekie beekiekedeee with 25.0 g (0.55 ml) of deaoetamido-4-hydroxy-5-methoxy-cinnamic acid acetate, 500 ml of methanol and 0.56 ml of 50% Neon. Adtekieven eettee under a pressure of 2.46 kp / cm? overpressure with a mixture of N2 and H2 (50:50). A catalyst solution was prepared by dissolving 0.050 g (0.025 meq.) ¿§H (4,5-hexediene) c; 7ë 1 0.5 ml of the benene, then adding 0.051 meq under a nitrogen atmosphere. (+) - methyloyclohexyl-o-anisylphosphine (optical purity about 90%) in 2.4 ml of benzene. Hydrogen was bubbled through this solution for 10 minutes, Rhodium »1,5-hexadiene chloride, see Examples 4 and 5 here Example 22: above. but obtained on this eat: (+) meey1eyk1enexy1-e-enieyl- feefin, hydrogen kefermig, kekpunke 110-114 ° o / 0.09 mena- / d7š ° = + 9s, 5 @ (e = «1 meon) at 90% .epe1ek purity ¿d / § ° = + s9 ° (e = 1 in MeOH).
Katalysatorlösningen infördes därefter i autoklaven och hydreringen genomfördes vid 60°C. Den var slutförd på 4 tim- mar. Produkten, nämligen N-acetyl-5-(4-hydroxí-5-metoxi- fenyl)-alaninacetat, som utvanns genom föràngning av lös- ningsmedlet, hade specifik vridning lä/â5= +58,2 (Na salt i vatten). Rent N¥acetyl-5-(4-hydroxi-5-metoxifenyl)-I» alaninacetat, också i form av natriumsalt i vatten, hade specifik vridning /&]â5= +54,0°. Den optiska renheten hos den erhållna hydreringsprodukten var sålunda 70,7 % eller bättre än 85 % av Ieenantiomeren ooh 15 % av D-enantiomeren.The catalyst solution was then introduced into the autoclave and the hydrogenation was carried out at 60 ° C. It was completed in 4 hours. The product, namely N-acetyl-5- (4-hydroxy-5-methoxyphenyl) -alanine acetate, which was recovered by evaporation of the solvent, had specific rotation lä / â5 = +58.2 (Na salt in water). Pure N-acetyl-5- (4-hydroxy-5-methoxyphenyl) -alanine acetate, also in the form of sodium salt in water, had a specific rotation of + 54.0 °. Thus, the optical purity of the resulting hydrogenation product was 70.7% or better than 85% of the enantiomer and 15% of the D-enantiomer.
Det ovan beskrivna förfarandet upprepades med (-)-metyl- cyklohexyl-0-anisylfosfin (optisk renhet ca 80 %). Man erhöll en hydreringsprodukt innehållande en huvudmängd av D-enantio- meren (optisk renhet hos reaktionsproduktblandningen var 65 %). Genom lämpligt val av (+)- eller (-)-fosfinen kan man sålunda framställa respektive enantiomer i stort utbyte.The procedure described above was repeated with (-) - methylcyclohexyl-O-anisylphosphine (optical purity about 80%). A hydrogenation product containing a major amount of the D-enantiomer was obtained (optical purity of the reaction product mixture was 65%). By appropriate choice of the (+) - or (-) - phosphine, one can thus produce the respective enantiomers in large yield.
Exempel 2§: Det i exempel 22 beskrivna förfarandet upprepa- des med användning av (-)-metylcyklohexyl-0-anisylfosfinen (epeiek renhet ee so %) lä/š°= -75,6° (e=« 1 neon) sem den optiskt aktiva liganden och a-bensamido-4-hydr0xi~5-metoxi- kanelsyra som den B-substituerade a-acylamidoakrylsyran. Den erhållna hydreringsprodukten utgjordes av N¥bensoyl-5-(4- hydroxi-5-metoxifenyl)-alanin innehållande en huvudmängd av fv9ooss4+7 10 45 20 25 50 ~35 28 D-enantiomeren (optisk renhet hos reaktionsproduktbland- ningen cirka 65 %).Example 2 §: The procedure described in Example 22 was repeated using the (-) - methylcyclohexyl-O-anisylphosphine (epeiek purity ee so%) lä / š ° = -75.6 ° (e = «1 neon) sem the optically active ligand and α-benzamido-4-hydroxy-5-methoxycinnamic acid as the β-substituted α-acylamidoacrylic acid. The resulting hydrogenation product was N-benzoyl-5- (4-hydroxy-5-methoxyphenyl) -alanine containing a major amount of the phosphorus 4 + 7 10 45 20 25 50 ~ 35 28 D enantiomer (optical purity of the reaction product mixture about 65% ).
Exempel 24: I en tryckkolv, som renblåsts med kväve, sat- sades a-bensamido-4-hydroxi-5-metcxi-kanelsyra (1,67 g, 5,0 mol), cykloaktadien-1,5-bis(metylcyklohexyl-o-anisylfosfin) iridiumtetrafluorborat,.klarröd, fast substans (24,7 mg, 0,025 mol), och 20 ml vattenfri metanol. Blandningen omrördes och genombubblades med kväve i 15 minuter. Trycket i tryck- kolven höjdes till 7 kp/cmz övertryck genom inblàsning av väte, och blandningen omrördes och upphettades vid 100°C i 4 timmar 20 minuter. En portion av denna reaktionsblandning underkastades NHR-spektrometrisk analys, varav det framgick att 59 % av utgångsmaterialet hade omvandlats till produkten 5 N#bensoyl-5-(4-hydroxi-5-metoxifenyl)-alanin. Genom polari- metrisk analys av reaktionsblandningen efter neutralisation enligt standardförfaranden framgick det, att produkten var poptiskt aktiv med fd/â“= 9,5°.Example 24: In a pressure flask purged with nitrogen, α-benzamido-4-hydroxy-5-methoxy-cinnamic acid (1.67 g, 5.0 mol), cycloactadiene-1,5-bis (methylcyclohexyl) was charged. o-anisylphosphine) iridium tetrafluoroborate, clear red solid (24.7 mg, 0.025 mol), and 20 ml of anhydrous methanol. The mixture was stirred and purged with nitrogen for 15 minutes. The pressure in the pressure flask was raised to 7 kp / cm 2 overpressure by blowing hydrogen, and the mixture was stirred and heated at 100 ° C for 4 hours 20 minutes. An aliquot of this reaction mixture was subjected to NHR spectrometric analysis, which showed that 59% of the starting material had been converted to the product N # benzoyl-5- (4-hydroxy-5-methoxyphenyl) -alanine. Polarimetric analysis of the reaction mixture after neutralization according to standard procedures showed that the product was poptically active with fd / â “= 9.5 °.
Exempel 253 I en lösning av 2,005 g N%acetyl-indolyl-a- acetamidoacrylsyra i 60 ml metanol sattes 0,00?4 g cyklo-~ oktadien--1,5-bis(metylcyklohexy1-o-anisylfosfin)rodiumtetra- fluorborat, orangefärgade kristaller med en smältpunkt av 170-175°c. Den så erhållna massan renbiastes omsorgsfullt, först_med kväve och därefter med väte, och omördes därefter under ett väteövertryck av 2,7 kp/cm? vid 25°C, Hydreringen till N,N'-diacetyl-tryptofan slutfördes på 2,5 timmar. Iös- ningen utspäddes till 400 ml och analyserades med avseenden på optisk vridningsförmâga. Iösningen hade Z&]êP= 20,fl°.Example 253 To a solution of 2.005 g of N% acetyl-indolyl-α-acetamidoacrylic acid in 60 ml of methanol was added 0.004 g of cyclooctadiene-1,5-bis (methylcyclohexy-1-o-anisylphosphine) rhodium tetrafluoroborate, orange crystals with a melting point of 170-175 ° C. The mass thus obtained was carefully purified, first with nitrogen and then with hydrogen, and then stirred under a hydrogen overpressure of 2.7 kp / cm? at 25 ° C, The hydrogenation to N, N'-diacetyl-tryptophan was completed in 2.5 hours. The solution was diluted to 400 ml and analyzed for optical torque. The solution had Z &] êP = 20, fl °.
Teoretiskt värde för den rena optiska enantiomorfen är 25,9°.- Man hade sålunda erhållit en optisk renhet av 77,5 %. Pro-0 dukten kan isoleras genom att lösningsmedlet förångas och återstoden krístalliseras.The theoretical value for the pure optical enantiomorph is 25.9 °. An optical purity of 77.5% had thus been obtained. The product can be isolated by evaporating the solvent and crystallizing the residue.
Exempel 26: Optiskt aktivt metylpropylfenylarsin framställes på sätt som angíves av Mislow och medarbetare i JACS gå, 955 (1975)- 0 - .En katalysatorlösning framställdes genom sammanblandning av 2 ml metanol, 0,2 g (+)-metylpropylfenylarsin ([d]šP= +10,7°, 80 %, 0,16 mmol) och 0,025.g rodium(cyklooktadien- 4»5)-acetonylacetonat(0,08 mmol), smältpunkt 425-428?C (sön- >derdelning). Efter omrörning i 10 minuter under kväveatmosfär 40 45 25 50 55 29 'raoossfl-rv hade hela mängden fasta beståndsdelar gått i lösning. En lösning av 4,0469 g a-acetamid0-4-hydroxi-5~metoxi-kanel- syraacetat i 25 ml metanol renblåstes omsorgsfullt med kväve och sattes därefter under ett väteövertryck av 5,9 kp/cm? vid 50°C. Till reaktionsblandningen sattes genom ett septum 4,0 ml av den ovan angivna katalysatorlösningen. Hydreringen började och var slutförd på 2,5 timmar, vilket framgick av ett tryckfall om 0,8 kp/omg. Den resulterande massan utspäd- des till 50 ml och provades med avseende på specifik optisk vridningsförmåga, som visade sig vara /à]šP= -2,55°. En testlösning med användning av rent N-acety1-3(4-hydroxi~5- metoxi-fenyl)-Ifalaninacetat och samma mängd katalysator gav en korrektion av denna vridningsförmåga för katalysatorn av O,7°. Hydreringen gav sålunda en nettovridning av -1,8°.Example 26: Optically active methylpropylphenylarsine is prepared as described by Mislow and co-workers in JACS go, 955 (1975) - 0 -. A catalyst solution was prepared by mixing 2 ml of methanol, 0.2 g (+) - methylpropylphenylarsine ([d] šP = + 10.7 °, 80%, 0.16 mmol) and 0.025 g rhodium (cyclooctadiene-4 »5) -acetonylacetonate (0.08 mmol), m.p. 425-428 ° C (dec.). After stirring for 10 minutes under a nitrogen atmosphere 40 45 25 50 55 29 'raooss fl- rv the whole amount of solids had gone into solution. A solution of 4.0469 g of α-acetamide-4- hydroxy-5-methoxy-cinnamic acid acetate in 25 ml of methanol was carefully purged with nitrogen and then placed under a hydrogen overpressure of 5.9 kp / cm at 50 ° C. To the reaction mixture was added through a septum 4.0 ml of the above catalyst solution. The hydrogenation began and was completed in 2.5 hours, as evidenced by a pressure drop of 0.8 kp / omg. The resulting mass was diluted to 50 ml and tested for specific optical torsional power, which was found to be / α] β = -2.55 °. A test solution using pure N-acetyl-3- (4-hydroxy-5-methoxy-phenyl) -phalanine acetate and the same amount of catalyst gave a correction of this torsional ability of the catalyst of 0.7 °. The hydrogenation thus gave a net rotation of -1.8 °.
Den rena optiska enantiomorfen hade [Ä/%P= ~40,8°. Den op- tiska renheten var således 4,4 %.The pure optical enantiomorph had [/ /% P = 4040.8 °. The optical purity was thus 4.4%.
Bevis för att arsinet icke var optiskt rent erhölls genom dess omvandling ti1l_sulfiden (Mislow och medarbetare i JACS 92, 955 (4973))och mätning av den optiska renheten med ett kemiskt förskjutningsreagens (NMR Chiral Shift Reagent, Whitesides och medarbetare JACS gg, 1058 (1974)). Detta försök visade att det använda metylpropylfenylarsinet hade en optisk renhet av endast 45 %. Om sålunda hydreringen hade genomförts med det optiskt rena arsinet, hade en optisk renhet av 9,5 % uppnåtts. Genom avdrivníng av metanolen och omkristallisation ur den koncentrerade lösningen utvanns produkten§ Exempel 22: Framställning av cyklooktadien-1,5-bís(metyl- cyklohexyl-o-anisylfosfin)-rodiumtetrafluorborat. I en_4- liters kolv satsades under kväve 500 ml metanol och 15,4 g (0,054 mol Zšbdium-(cyklo-oktadien-1,5)klorid]è. 50,5 g (98 %, 0,42 mol) metyícyklohexyl-o-anisylfosfin sattes till lösningen och det hela omrördes i 1/2 timme, varigenom man erhöll en röd/orange lösning. Iösningen av natriumtetrafluor- here: 015,? g, 0,42 mel) i 'neo m1 vatten tillsattes under loppet av en timme. Orangefärgade kristaller avskiljde sig och uppsamlades. De tvättades med vatten (2x3O ml). Produk- ten torkades under vakuum vid 25°O och vägdes. Man erhöll på detta sätt 45 g produkt med en smältpunkt av 470-175°C. Detta material var till cirka 96 % optiskt rent.Evidence that the arsine was not optically pure was obtained by its conversion to the sulfide (Mislow et al. In JACS 92, 955 (4973)) and measurement of the optical purity with a chemical shift reagent (NMR Chiral Shift Reagent, Whitesides and co-workers JACS gg, 1058 ( 1974)). This experiment showed that the methylpropylphenylarcin used had an optical purity of only 45%. Thus, if the hydrogenation had been carried out with the optically pure arsine, an optical purity of 9.5% would have been achieved. By evaporation of the methanol and recrystallization from the concentrated solution, the product was obtained. Example 22: Preparation of cyclooctadiene-1,5-bis (methylcyclohexyl-o-anisylphosphine) -rodium tetrafluoroborate. In a 4 liter flask was charged under nitrogen 500 ml of methanol and 15.4 g (0.054 mol of Zsbdium- (cyclooctadiene-1.5) chloride] and 50.5 g (98%, 0.42 mol) of methicyclohexyl-o -anisylphosphine was added to the solution and the whole was stirred for 1/2 hour to give a red / orange solution.The solution of sodium tetrafluorene: 015 .mu.g, 0.42 ml) in 1 ml of water was added over a period of hour. Orange crystals separated and were collected. They were washed with water (2 x 30 ml). The product was dried under vacuum at 25 ° O and weighed. 45 g of product with a melting point of 470-175 ° C were obtained in this way. This material was approximately 96% optically pure.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3647170A | 1970-05-11 | 1970-05-11 | |
US12211671A | 1971-03-08 | 1971-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7900354L SE7900354L (en) | 1979-01-15 |
SE430219B true SE430219B (en) | 1983-10-31 |
Family
ID=26713195
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7106040A SE400552B (en) | 1970-05-11 | 1971-05-10 | PROCEDURE FOR ASYMMETRIC HYDRATION OF A BETA-SUBSTITUTED ALFA ACYLAMINOACRYLIC ACID IN THE PRESENCE OF A CATALYST IN THE FORM OF A METAL COORDINATION COMPLEX IN COMBINATION WITH AN OPTICAL ACTIVE |
SE7409525A SE410463B (en) | 1970-05-11 | 1974-07-22 | METHYLYCLOHEXYL-O-ANISYLPHOSPHINE FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF OPTICALLY ACTIVE HYDRATION CATALYSTS |
SE7409524A SE412394B (en) | 1970-05-11 | 1974-07-22 | ASSOCIATION FOR APPLICATION AS A CATALYST AT THEY ASYMMETRIC HYDROGEN. |
SE7900355A SE430220B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
SE7900354A SE430219B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7106040A SE400552B (en) | 1970-05-11 | 1971-05-10 | PROCEDURE FOR ASYMMETRIC HYDRATION OF A BETA-SUBSTITUTED ALFA ACYLAMINOACRYLIC ACID IN THE PRESENCE OF A CATALYST IN THE FORM OF A METAL COORDINATION COMPLEX IN COMBINATION WITH AN OPTICAL ACTIVE |
SE7409525A SE410463B (en) | 1970-05-11 | 1974-07-22 | METHYLYCLOHEXYL-O-ANISYLPHOSPHINE FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF OPTICALLY ACTIVE HYDRATION CATALYSTS |
SE7409524A SE412394B (en) | 1970-05-11 | 1974-07-22 | ASSOCIATION FOR APPLICATION AS A CATALYST AT THEY ASYMMETRIC HYDROGEN. |
SE7900355A SE430220B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS5320011B1 (en) |
BE (1) | BE766960A (en) |
CA (1) | CA937573A (en) |
CH (1) | CH563346A5 (en) |
DE (1) | DE2123063C3 (en) |
FI (1) | FI55992C (en) |
FR (1) | FR2100644A1 (en) |
HU (1) | HU164803B (en) |
IL (1) | IL36804A (en) |
IT (1) | IT1019513B (en) |
NL (1) | NL155004B (en) |
NO (1) | NO142075C (en) |
RO (1) | RO80693A (en) |
SE (5) | SE400552B (en) |
SU (2) | SU640659A3 (en) |
YU (1) | YU35559B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4008281A (en) | 1973-12-03 | 1977-02-15 | Monsanto Company | Asymmetric catalysis |
US4376870A (en) * | 1980-12-05 | 1983-03-15 | Monsanto Company | Optically active phosphine compounds |
EP0077099A3 (en) * | 1981-10-08 | 1983-08-03 | ANIC S.p.A. | Process for preparing amino acids and their esters |
-
1971
- 1971-05-07 NL NL717106286A patent/NL155004B/en not_active IP Right Cessation
- 1971-05-10 IT IT24322/71A patent/IT1019513B/en active
- 1971-05-10 NO NO1757/71A patent/NO142075C/en unknown
- 1971-05-10 JP JP3056471A patent/JPS5320011B1/ja active Pending
- 1971-05-10 FR FR7116805A patent/FR2100644A1/en active Granted
- 1971-05-10 CA CA112638A patent/CA937573A/en not_active Expired
- 1971-05-10 RO RO7166836A patent/RO80693A/en unknown
- 1971-05-10 DE DE2123063A patent/DE2123063C3/en not_active Expired
- 1971-05-10 SE SE7106040A patent/SE400552B/en unknown
- 1971-05-10 IL IL36804A patent/IL36804A/en unknown
- 1971-05-10 BE BE766960A patent/BE766960A/en not_active IP Right Cessation
- 1971-05-10 FI FI1283/71A patent/FI55992C/en active
- 1971-05-10 CH CH689171A patent/CH563346A5/xx not_active IP Right Cessation
- 1971-05-10 HU HUMO793A patent/HU164803B/hu not_active IP Right Cessation
- 1971-05-10 SU SU711654953A patent/SU640659A3/en active
- 1971-05-11 YU YU1160/71A patent/YU35559B/en unknown
-
1974
- 1974-02-14 SU SU1995600A patent/SU526279A3/en active
- 1974-07-22 SE SE7409525A patent/SE410463B/en unknown
- 1974-07-22 SE SE7409524A patent/SE412394B/en unknown
-
1979
- 1979-01-15 SE SE7900355A patent/SE430220B/en unknown
- 1979-01-15 SE SE7900354A patent/SE430219B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2100644B1 (en) | 1973-06-08 |
SE412394B (en) | 1980-03-03 |
JPS5320011B1 (en) | 1978-06-24 |
SE410463B (en) | 1979-10-15 |
NO142075B (en) | 1980-03-17 |
SU526279A3 (en) | 1976-08-25 |
HU164803B (en) | 1974-04-11 |
FI55992C (en) | 1979-11-12 |
SU640659A3 (en) | 1978-12-30 |
CH563346A5 (en) | 1975-06-30 |
FR2100644A1 (en) | 1972-03-24 |
DE2123063B2 (en) | 1977-11-24 |
BE766960A (en) | 1971-11-10 |
SE430220B (en) | 1983-10-31 |
DE2123063C3 (en) | 1978-07-20 |
SE400552B (en) | 1978-04-03 |
FI55992B (en) | 1979-07-31 |
IT1019513B (en) | 1977-11-30 |
YU35559B (en) | 1981-04-30 |
SE7409524L (en) | 1974-07-22 |
NL7106286A (en) | 1971-11-15 |
NO142075C (en) | 1980-06-25 |
IL36804A0 (en) | 1971-07-28 |
SE7409525L (en) | 1974-07-22 |
IL36804A (en) | 1978-06-15 |
CA937573A (en) | 1973-11-27 |
DE2123063A1 (en) | 1971-12-02 |
SE7900355L (en) | 1979-01-15 |
NL155004B (en) | 1977-11-15 |
RO80693A (en) | 1982-12-06 |
SE7900354L (en) | 1979-01-15 |
YU116071A (en) | 1980-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burk et al. | New chiral phospholanes; synthesis, characterization, and use in asymmetric hydrogenation reactions | |
EP0036741B1 (en) | Phosphine compounds, transition metal complexes thereof and use thereof as chiral hydrogenation catalysts | |
ES2708693T3 (en) | Method for producing compound with carbonyl group using ruthenium-carbonyl complex having tridentate ligand as oxidation dehydrogenation catalyst | |
CA2502342C (en) | Ruthenium complexes as (pre)catalysts for metathesis reactions | |
US4691037A (en) | Ruthenium-phosphine complex | |
SU663273A3 (en) | Optically active catalyst for asymmetrical hydrogenation of substituted acrylic acids | |
EP1042333B1 (en) | Schiff base derivatives of ruthenium and osmium olefin metathesis catalysts | |
JPH0145478B2 (en) | ||
US4604474A (en) | Rhodium-phosphine complex | |
HU217368B (en) | Chiral 2,5-dialkyl phospholanes, preparation thereof and enantioselective hydrogenating catalysts containing said compounds as ligands | |
Loeber et al. | Multifunctional phosphane and phosphane oxide ligands derived from p-tert-butylcalix [4] arene. Synthesis of a large diphosphane with C2 symmetry and behaving as a cis or trans binding ligand | |
US4124533A (en) | Metal coordination complexes containing optically active phosphine or arsine ligands | |
JPH0733392B2 (en) | 2,2'-bis [di (m-tolyl) phosphino] -1,1'-binaphthyl | |
Lo Schiavo et al. | Rhodium-palladium and rhodium-platinum heterobinuclear complexes containing the 2-(diphenylphosphino) pyridine short-bite bridging ligand. X-ray crystal structure of [(. eta. 5-C5H5)(CNBut) Rh (. mu.-Ph2PPy) Pd (CNBut) Cl] PF6 | |
Tóth et al. | Enantioselective two-phase hydrogenation of α-amino acid precursors with water soluble rhodium complexes of the cationic ligand (S, S)-2, 4-bis [bis-(pN, N, N-trimethylammoniumphenyl) phosphino] pentane,[CH 3 CH (P (pC 6 H 4 NMe 3) 2 CH 2 CH (P (pC 6 H 4 NMe 3) 2 CH 3] 4+ | |
EP0271310B1 (en) | Ruthenium-phosphine complexes | |
Van der Zeijden et al. | Unusual isomerization of ortho-chelated aryliridium (I) complexes, involving a unique sequence of intramolecular carbon-hydrogen bond-making and-breaking processes. X-ray structure of IrI [C6H3 (CH2NMe2) 2-2, 4](COD) | |
Zwick et al. | A novel heterobimetallic asymmetric hydrogenation catalyst based upon a chiral rhenium template containing two phosphido substituents | |
Jun et al. | Synthesis, Reactions, and Rearrangement of X (PR'3) 2M [C (: PR) X](M= Pt, Pd; X= Cl, Br; R'= Et, Ph; R= 2, 4, 6-tri-tert-butylphenyl): Mechanism of the Transition Metal Promoted Conversion of X2C: PR to RC. tplbond. P | |
US4764629A (en) | Ruthenium-phosphine complex | |
EP0582668A1 (en) | Chiral tridentate bis(phospholane) ligands | |
US4261919A (en) | Catalytic asymmetric hydrogenation | |
US4265827A (en) | Catalytic asymmetric hydrogenation | |
JP4201916B2 (en) | Optically active 1,2-bis (dialkylphosphino) benzene derivative, process for producing the same, and rhodium metal complex having the compound as a ligand | |
SE430219B (en) | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |